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Abstract
Ventilator associated pneumonia (VAP), a major source of infection in Intensive Care Unit 
(ICU) that leads to higher mortality and cost. The PICO format is: Population: Adults with 
endotracheal tube (ETT) intubations during ICU stay. Intervention: The ® Kimberly Clark High 
Volume Low Pressure Micro Cuffed (KC) ETT for adults intubated in ICU. Comparison: The 
High Volume Low Pressure ETT ®Mallinckrodt (MK). Outcome: Reduce VAP incidence and 
improve patient outcomes. Do ICU adults intubated with KC ETTs have fewer VAPs than those 
intubated with the MK? VAP starts with pathogen’s (Craven, 2006). Deem and Treggiari (2010) 
believes the ETT does impacts this pneumonia. Spiegel (2010) feels the newer cuffed ETTs seals 
the trachea, reducing aspirations, and that reduces VAP. Did the KC ETT decrease VAP 
incidence, compared to the MK? The main objectives are to determine if there are decreased 
VAPs with the KC ETT compared to the MK. Did compliance to the VB remain 100%, and did 
the number of ventilator days make any difference in the two ETTs and VAP rates. A descriptive 
retrospective data showed no significant difference in the number of VAPs based on the ETTs. 
There were more ventilator days with the KC; 821 than the MK at 580 indicating a difference 
between the number of ventilator days. The VAP rates for MK 1.7, the KC was 2.4. VB 
compliance did remain100%.
Key words: VAP, ETTs design, Kurt Lewin CT, DNP Capstone Project
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EXECUTIVE SUMMARY 
Problem
The practice issue is, that even with ventilator bundles (VB) at 100% compliance, ventilator 
associated pneumonia (VAP) is a major source of infection in the Intensive Care Unit (ICU), and 
leads to higher mortality and cost in the intubated adult patient. The PICO format is: Population: 
Adults with endotracheal tube (ETT) intubations during ICU stay. Intervention: The ® Kimberly 
Clark High Volume Low Pressure Micro Cuffed (KC) ETT for adults intubated in ICU. 
Comparison: The High Volume Low Pressure ETT the ®Mallinckrodt (MK). Outcome: Reduce 
VAPs in ICU and improve patient outcomes. While in ICU, do adults intubated with KC ETTs 
have fewer VAPs than those intubated with the MK? Evidence shows that VAP starts with 
pathogen’s (Craven, 2006). Deem and Treggiari (2010) agree, and supports VAP prevention at 
the time of the intubation and believes the design of the ETT impacts VAP incidence. Spiegel 
(2010) supports the use of the KC ETT and feels this newer cuff seals the trachea better and 
reduces aspirations, and that reduces VAP.
Purpose
The purpose of the Capstone Project (CP) was to determine if the KC ETT resulted in a decrease 
in VAP incidence, compared to the MK. Investigation into the role that the ETT plays in the 
reduction of a VAP must continue to be pursued.
Goal
The main goal to provide the best evidenced based practice (EBP) interventions to assure the 
most favorable outcome to the intubated and mechanically ventilated (MV) adult ICU patient.
Objectives
The main objectives were to determine if there are decreased VAPs with the KC ETT compared 
to the MK. Did compliance to the VB remain 100%, and did the number of ventilator days make 
any difference in the two ETTs and VAP rates.
Plan
Outcome plans: evaluate equally in twelve month periods the KC and MK on VAP incidence,
VB compliance, ventilator days and VAP rates in the KC and MK in comparative periods. 
Application of the two-sample t-test, p value of .05, and a confidence interval of 95%, used to 
aid in the analysis, reliability and validity of the findings, and in the interpretation of the results 
of the outcomes identified. All findings will be disseminated.
Outcomes and Results
The CP results using the two sample t-test showed that there was no significant difference in the 
number of VAPs based on the two ETTs; there were more ventilator days with the KC at 821 
than the MK at 580 which indicates there was a significant difference between the numbers of 
ventilator days. The VAP rates/1000ventilator days, for the two ETTs were as follows: MK VAP 
rate was 1.7 and the KC was a 2.4 VAP rate. In addition, the VB compliance remained at 100% 
for both 12 month time periods.
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Use of High Volume Low Pressure Microcuffed Endotracheal Tubes to Reduce Ventilator
Associated Pneumonia.
What is a Capstone Project (CP) and how does it relate to preventing ventilator associated 
pneumonias (VAP)? The CP is the final step of the Doctorate of Nursing Practice (DNP) 
program. It is reflecting a demonstration of synthesis and mastery of an advanced subject within 
the practice of nursing by the student completing their final academic steps (Zaccagnini &
White, 2011). The purpose of a CP is to improve a practice and or a patient care outcome, and 
also set the tone for continuous improvement through evidence based practice (EBP) 
interventions (Zaccagnini & White, 2011).
The purpose of this project and paper was to provide in writing the CP problem recognition 
and definition, review of evidence, project plan and evaluation, project findings and results, 
limitations, recommendations, and implications for change with the aim of determining if the 
evidence indicates that the use of the newer designed endotracheal tubes (ETTs) did result in 
decreased VAP incidence and did promote better patient care outcomes.
Problem Recognition and Definition 
Statement of Purpose Appropriate for Evidence-based Project
The main purpose of this CP was to ascertain whether there is strong evidence to support the 
use of newer designed ETT like the polyurethane ®Kimberly Clark high volume low pressure 
microcuffed (KCHVLPMC) ultrathin tube in decreasing VAP rates, compared to other high 
volume low pressure tube designs like the ®Mallinckrodt (MK). In addition, did investigation 
into the role that the two ETT designs play in the reduction of VAPs need to be pursued further. 
This could possibly save lives, decrease mortality and morbidity, reduce health care costs, and 
hospital days and result in better patient care outcomes.
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Problem Statement/Change Clearly Identified
Starting out with the practice issue of concern, and using the recognized abbreviation PICO 
which includes the Population of concern, Intervention, Comparison method, and Outcome 
(PICO); a PICO statement was created, data was collected that could possibly support changes in 
practice that are evidence based and best practice methods, thus resulting in better patient care 
outcomes. The problem issue clearly identified was that there remains an increased incidence of 
VAP in spite of ventilator bundle (VB) protocols and 100% ventilator quality indicator (QI) 
compliance, and other EBP strategies. Based upon the evidence VAP is still occurring and 
remains a leading cause of hospital acquired infections (HAIs) (Bird, Zambuto, O’Donnel, Silva, 
Korn, Burke, Burke, & Agarwal, 2010). Further inquiry into the problem issue was constructed 
as an EBP question and included the patient population, intervention, comparison, and outcome, 
known as PICO.
PICO Articulated and Leads to Question
The PICO Format: In adult patients undergoing oral intubation while hospitalized in Intensive 
Care Unit (ICU), do patients who are orally intubated with the KCHVLPMC ETT have fewer 
VAPs than those who are intubated with other high volume low pressure ETTs like the MK? The 
PICO format is:
P-Population: Adults with oral ETT intubations during ICU hospitalization. 
I-Intervention: Use of improved KCHVLPMC ETT for adult oral intubations in ICU. 
C-Comparison: Another high volume low pressure ETT like the MK.
O-Outcome: Reduce or eliminate all incidences of VAP in ICU and provide better 
patient care outcomes.
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The final question is: In adult ICU patients undergoing oral intubation while 
hospitalized in ICU, do patients who are orally intubated with the KCHVLPMC ETT have fewer 
VAPs than those who are intubated with other commercially designed high volume low pressure 
ETTs?
Project Significance, Scope, and Rationale
The project significance is VAP continues to be a major infection in ICU, leading to higher 
morbidity and mortality and an overwhelming health care cost factor in the intubated adult 
patient population. Conducting this CP was an exceptional opportunity to possible play an 
important part in reducing the occurrence of this pneumonia. VAP is linked with the ETT 
instrumentation used to maintain the airway (Deem & Treggiari, 2010). The ETT can contribute 
to the aspiration of infected secretions that can establish just the right environment for a VAP to 
develop (Deem & Treggiari, 2010). It is critical that future research into the effects the ETT 
design has on the prevention of VAP be continued (Deem & Treggiari, 2010). It is equally 
important that future studies of ETTs designed to prevent VAP demonstrate effectiveness, and 
show evidence of improved patient care outcomes, safety, and cost (Deem & Treggiari, 2010). A 
multifaceted approach that includes the use of the ventilator bundle (VB) along with the 
initiation of the newer designed KCHVLPMC ETT may reduce VAP incidence and this method 
should be investigated further to determine its effectiveness and, that was the main rationale for 
this CP. Add to this, all VAP incidences from hospitals are also reported to the Center for 
Disease Control and Prevention (CDC) and are available to the community for viewing. This 
data is often used by the public when choosing a hospital for care delivery. Preventing VAP is a 
huge priority in ICU and adding to this precedence is the pressure being put on hospitals to
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eliminate HAIs like VAP or face reductions in reimbursement from health insurance providers 
like Medicare and Medicaid and others (Bird et al., 2010).
Evidence suggests a VAP starts with a host factor and pathogen (Craven, 2006). Knowing 
this, several different prevention guidelines must be initiated at the time of the intubation. 
Pulmonary experts like Deem and Treggiari (2010) and Blot, Rello, and Vogelaers (2011) agree 
guidelines should focus on reducing the host factor and colonization of pathogens that contribute 
to a VAP. Craven (2006) realized prevention of aspiration into the lung field, effective antibiotic 
treatment, limited, or omitting the use of invasive devices such as nasal intubation and gastric 
tubes are areas for primary focus.
Even with the initiation of preventive measures and the development of VAP standing orders, 
hospitals still have not reached the expected number of reduced occurrences. The evidence 
suggests perhaps the design of the ETT being used for intubations may be a contributing factor to 
the lack of reduction of VAP incidence. However, Spiegel (2010) reports not being convinced 
that changing the design or contour of the ETT will reduce the VAP occurrences but does feel 
there is merit in changes in the cuff design which may improve sealing the trachea area better. 
This may reduce aspiration of contaminated secretions, which in turn may decrease VAP 
occurrences.
The KCHVLPMC ETT is an ultrathin high volume ultra low pressure cuff specifically 
invented to be above average in sealing the trachea location (Spiegel, 2010). Lorente, Blot, and 
Rello (2010) reports newer strategies such as the design of a ETT that is an ultrathin cuffed and 
low-volume low pressure cuff device is also being investigated as a possible answer to the 
reduction of VAP incidence. In 2008, a study conducted at a hospital in Tampa, Florida using the 
KCHVLPMC ETT demonstrated a 60% drop in VAP’s as reported by the Head of Anesthesia
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(Karlnoski, Kolla, Munoz, Downes, Thompson, Klacsan, & Kelley, n.d.). Spiegel (2010) also 
reported this ETT showed a 43% decrease in VAP incidence. On the basis of this evidence and 
support, there is justification for further research into what is best in practice, and it should be 
pursued.
Theoretical Foundation for Project and Change
The theoretical foundation for the CP and any possible change in practice incorporates the 
use of the Kurt Lewin change theory (CT) known as unfreeze, change, and refreeze stages and 
would contribute even further in the successful implementation of EBP changes that promote the 
best patient outcome. The best patient care outcome would be recognized as evident by the 
reduction of VAP occurrences in ICU. First, unfreeze the present practice which was done in 
January 2012 when the KCHVLPMC ETT replaced the MK ETT. Next, make the change, which 
was done and started January 2012 with the implementation of the KC tube for all adult 
intubations, and evaluate the outcome over a stated period of time. If the change results in a 
reduction of VAP incidence and better patient care outcomes were achieved, refreeze the practice 
and keep the KCHVLP ETT. Next, it would be important to establish procedures and policies to 
preserve the practice until another change is deemed necessary (Kaminski, 2011).
Literature Selection/Systematic Review of Literature/Process Supports Problem
A literature selection and systematic process supporting the VAP problem was conducted.
The literature subject goal of the CP was to address the problems associated with VAP incidence, 
and to better understand the difficulties involved, in hope of finding improved EBP interventions 
that contribute to the best outcome possible for the patient. An extensive literature review by 
means of a systematic process was conducted over the entire course of the DNP program. Using 
databases such as PUBMED, CIHNAL, MD Consult, Cochrane, MEDLINE Agency for
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Healthcare Quality and Research (AHRQ) and searching key words including ETT designs, VAP 
prevention, VB protocol, EBP, CDC definition of a VAP and Kurt Lewin’s CT, and searching 
for levels of evidence that included levels I, II, III, IV, and V, and that were creditable based on 
systematic reviews, meta-analysis, randomized control trials (RCT), or evidence of one or more 
RCTs, case studies, qualitative studies or expert opinions. Included in this paper is the systematic 
review carried out to support the CP problem and practice issue of on-going VAP incidence 
(Appendix A). Need to add a sentence here that states the number of articles you found, how you 
narrow and your final number of articles included in your review and application to this project. 
Scope of Evidence is Summarized and Appropriate
The scope of evidence summation clearly reveals the practice issue of concern, which is 
VAP continues to be a major source of HAI in ICU, and contributes to higher morbidity and 
mortality and an overwhelming health care costs in this intubated adult patient population. The 
evidence is strong that a VAP starts with a host factor and pathogen. Knowing this, several 
different prevention guidelines must be initiated at the time of the intubation. These guidelines 
should focus on reducing the host factor and colonization of pathogens that contribute to a VAP. 
As stated earlier, Craven (2006) did realize prevention of aspiration into the lung field, antibiotic 
treatment, and limiting or omitting the use of invasive devices such as nasal intubations, nasal 
gastric tubes, and even central venous lines inserted up at the neck location are areas that must be 
of primary focus.
Even with the initiation of preventive measures, and the development of VAP standing orders, 
hospitals still have not reached the expected number of reduced occurrences, which is set at 
reaching a zero in events (Wahl, Zalewski, & Hemmila, 2011). The evidence continues to 
support that perhaps the design of the ETT being used for intubations may be a contributing
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factor to the lack of reduction in VAP incidence. As has been noted, Spiegel (2010) is not yet 
convinced changing the design or contour of the ETT will reduce the VAP occurrences but does 
feel there is merit in changes in the cuff design which has shown improved sealing of the trachea 
area better, and this may reduce aspiration of contaminated secretions, and that may decrease this 
type of pneumonia.
The KCHVLP ETT is an ultra low pressure cuff specifically invented to be above average in 
sealing in the trachea and, Spiegel, (2010) believes this is reducing the aspiration of 
contaminated secretions that contribute to VAP. Lorente, Blot, and Rello (2010) reported that 
newer strategies such as the design of ETT to be ultrathin cuffed and low-volume low pressure 
cuff devices are also a possible answer to the reduction of VAP because it too has demonstrated 
a reduction of the aspiration of these infected secretions. It is evident that further research into 
what is best in practice should be pursued. If the hospital in Florida who reported after using the 
KCHVLPMC ETT in practice showed a 60% drop in VAPs perhaps more healthcare facilities 
could as well.
Review of Evidence
Background of the Problem
The literature review on the background and problem of continued and persistent VAP 
incidence was executed. It concludes, in spite of the current strategies to prevent VAP in the 
mechanical ventilated (MV) adult ICU patient, this pneumonia remains the second most common 
HAI and carries a high mortality rate (Blot et al., 2011). It is an all encompassing and costly HAI 
is significantly related with the invasion of the ETT instrument used to maintain an airway (Blot 
et al., 2011). Contaminated secretions or fluids can bypass the ETT cuff and establish an
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environment in the lungs is right for bacterial infections to grow and develop into a VAP (Blot et 
al., 2011).
Systematic Review of the Literature
The systematic review of the literature substantiated that VAP is a hospital acquired 
pneumonia (HAP) and could affect a great number of people in the 18 years or older age group 
and rise significantly in the 65+ age group. It is one of the most common HAI in adult ICUs and 
a significant concern of clinicians today (Bird et al., 2010). It may account for up to 60 percent 
of all deaths from HAIs in the United States (U.S.) (Bird et al. 2010). Other key U.S. statistics 
includes the following: Approximately eight to 28 percent of critical care patients intubated 
during their stay in ICU will develop a VAP (Bird et al. 2010). This patient population carries a 
mortality rate of 15 to 25 percent (Bird et al., 2010). Add to this, mortality and morbidity of a 
VAP can be induced by other unpredictable variables which can affect this patient population, 
such as the timing of the onset of pneumonia, other diagnostic lines of attack, other contributing 
organism, and delays of needed interventions (Bird et al., 2010). VAP also increases the adult 
patient population time in the ICU by four to six days, and prevention of VAP is a main priority 
in all ICUs throughout the nation (Bird et al., 2010). VAP though reduced in incidence has not 
reached a zero percent rate. In some cases 10.2 VAP cases /1000 ventilator days has been 
reported in some trauma ICUs (Bird et al., 2010). In spite of the current strategies to prevent 
VAP in the MV adult ICU patient, this pneumonia still remains the second most common HAI 
and still carries a high mortality rate (Blot et al. 2011). It is a costly HAI that is significantly 
related with the invasion of the ETT instrument used to maintain an airway (Blot et al., 2011). 
The contaminated secretions or fluids as already stated earlier can bypass the ETT cuff and
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establish an environment in the lungs that is right for infections to grow and develop into a VAP 
(Blot et al., 2011). VAP prevention will most likely be best achieved by a multifaceted approach. 
This means not only with the continuation of current VAP prevention strategies such as basic 
infection control methods like excellent hand hygiene, proper patient positioning, effective 
mouth care, early removal of the ETT, but also considering the use of the newer designed ETT 
currently available and showing evidence of VAP incidence reduction.
Deem and Treiggari (2010) support the newer designed ETTs demonstrates evidence of VAP 
reduction must continue to be explored. Deem and Treiggari (2010) also believes there is strong 
support that further investigation into the effectiveness of current VAP prevention strategies 
along with novel prevention strategies like the newer designed ETT must continue. It is possible 
better patient care outcomes can be realized and reached with a multifaceted approach to VAP 
prevention strategies (Deem & Treiggari, 2010).
In 2010, the U.S. Census Bureau reported that the age group 65 and older is growing faster 
than the total U.S. population (United States Census Bureau, 2011). A hospital in the northern 
section of the U.S. where the data for the CP was obtained is a state identified as having above 
national average in the number of older adults 65+ age category (United States Census Bureau, 
2011). The major population at risk for a VAP is the adult patient who requires oral intubation 
while hospitalized in the ICU and was the key population of interest for the CP. This population 
is also often prone to infection just by the nature of the stressful hospital environment.
Therefore, further investigation into the effectiveness of current VAP prevention strategies along 
with novel prevention strategies like the newer designed ETT must be followed.
Project Plan and Evaluation
Market/Risk Analysis
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The strength, weakness, opportunity, and threat (SWOT) market/risk analysis was conducted 
on the CP and did aid in identifying the driving and restraining forces of the project. A SWOT 
analysis model was effective in guiding and identifying the health promotion and disease 
prevention needs for the population identified as at risk for a VAP, which is the adult patient who 
requires oral intubation while hospitalized in the ICU. Table 1 is the modified SWOT analysis 
conducted to target VAP rate reduction. It contains the lists of the identified strengths, 
weaknesses, opportunities, and threats that were the most beneficial acknowledgements utilized 
when searching for the most effective VAP prevention strategies.
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Project Strength, Weaknesses, Opportunities, and Threats
Table 1.
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SWOT Analysis
al
nr<u
nI
Strengths: Weaknesses:
• Staff at all levels of the organization are 
ready to get serious about HAI and VAP 
infection rates
• Policies and procedures to prevent the 
spread of infection are being enforced 
(Isolation). Hand washing before and 
after contact with the patient (pt)
• Ventilator Bundles are automatically 
initiated upon intubation followed by 
mechanical ventilation
• Endotracheal tube to reduce VAP 
incidence are trialed and used in all 
departments who intubate pts.
• Reward system in place to reward doing 
an excellent job and keeping the HAI 
and VAP rates down
• Equipment and Technology
• Lack of sense of accountability from some 
healthcare providers
• Ventilator Bundle implemented but not 
followed with 100% compliance
• Staff cut corners and are resistant to change 
( don’t follow isolation policies 
consistently)
• Inadequate or inappropriate staffing ratios
• CDC guidelines for the definition of a VAP 
vague and interpretation difficult and at 
times challenged
• Visitors and family members are not 
always supporting the cause to prevent the 
spread of infection in the pt room
• Poor communication
al
nr(U
nI
Opportunities: Threats:
• Patient and family involvement in 
infection control
• Keep entire organization engaged with 
changes in practice with effective and 
ongoing communication and policing 
each other
• Promote standardized practice for 
cleaning a room while occupied and 
after vacancy
• Get pharmacy involved and improve 
effective antibiotic usage
• Provide regular updates on HAI and 
VAP rates
• Re-evaluate rates and publish on a 
community board with a data analysis 
graphic chart
• Educate hospital associates in all 
departments on the non-payment for 
HAI occurring in the US hospitals
• Engage and involve multi-professional 
rounding and include pt and family
• Literature Search for Best Practice 
Protocols
• Making public aware of HAI and VAP 
rates when not favorable
• Financial ramification
• Other priorities competing for time and 
resources
• Doing nothing until forced to change
• Lack of education of VAP threat
• Poor hand hygiene
• Poor compliance to 
policies/procedures/protocols
• Poor staffing and ineffective leadership
• Lack of resources
• Other hospital departments that provide 
care to the pt besides the ICU
Driving/Restraining Forces
The driving force identified to implement the most current EBP VAP prevention strategies 
was to assure the MV ICU patient receives the best patient outcome possible. The restraining 
force to that possibility was identified and listed as weaknesses in the SWOT analysis, and was 
seen in the supply and demand areas of manpower. Being able to sustain a full workforce of 
qualified registered nurses (RN) and certified respiratory therapists (RT) was seen as a possible 
concern. Retention and recruitment of such skilled professional staff members will always have 
an impact on maintaining high quality care. The evidence indicates nurse-to-patient ratios are 
directly correlated to patient care outcomes (Aiken, Clarke, Slogane, Lake, & Cheney, 2009). In 
an effort to maintain high quality care to the MV patient in ICU ongoing efforts to retain and 
recruit highly qualified professional staff remains a priority at the facility where the CP was 
conducted in their 20 bed mixed ICU. Since a newly formed merger with a large healthcare 
service organization in July 2012, the hospital where the CP was conducted currently remains 
dedicated to providing their patients the best EBP care, which includes the use of the newer 
designed KCHVLPMC ETT for all intubations performed in their ICU. As a result of this merger 
a change in the ETT product other than the KCHVLPMC tube could be considered in the future, 
regardless of the outcome of this project. To date it remains the ETT of choice and has been 
throughout the CP process.
Need, Resources, and Sustainability
Vital implementation and ongoing monitoring of the project plan in order to facilitate any 
requested changes was conducted, and was based on the need, resources, and sustainability of the 
plan. The biggest need identified was the need to achieve Institution Review Board (IRB) 
approvals from Regis University, and the hospital granting permission for the CP to be
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conducted on their adult MV ICU patient population and keep the CP on the proposed timetable 
to be met. The resources in the form of data retrieval, and the staff who provided such for the CP 
were provided in a timely fashion, and after IRB approvals had been granted. Based on the 
ability to complete the CP in the time allotted sustainability was maintained with no real issues 
experienced.
Feasibility/Risks/Unintended Consequences
The information achieved through the CP is feasible and applicable in the day to day care of 
the MV patient and is currently being practiced in the ICU where the project was conducted. As 
far as a risk benefit analysis there was no direct risk to the patient population that data was 
collected on for the CP. All of the information collected came from a retrospective data source. 
The greatest benefit is keeping MV patients from further VAP incidence; that starts on day one 
with implementation of the VB. This includes assuring that the ventilator QI is done every day 
and documentation of best strategies to prevent VAP occurrence are implemented and strictly 
adhered to. There were no unintended consequences identified as a result of the CP data 
collection process.
Stakeholders and Project Team
The author’s opinion is that stakeholders are seen as any person, group or organization, 
members, or system that could be affected by an organization’s action. The stakeholders and 
project team members of the CP associated with VAP prevention were recognized as the adult 
ICU intubated patient and family members who were affected the most from the delivery of care 
outcome. Next were the members of the VAP committee where the CP was conducted which 
were, the Medical Director of Critical Care, the Director of Nursing, the Critical Care Unit 
(CCU/ICU) Nurse Manager and Clinical Nurse Educator and Chairperson, the Respiratory
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Therapy Manager and Coordinator, the Infectious Disease (ID) Nurse, and at times the Chief 
Nurse Officer (CNO) during a VAP occurrence investigation and review process. Also included 
were the staff members in CCU/ICU, the organization, and the author’s mentor and chairperson 
who provided guidance and support throughout the CP.
Cost/Benefit Analysis
A process that must be conducted when considering a practice change is the cost-benefit 
analysis (Longest, 2010). One question to be considered is, can the organization substantiate the 
higher cost that a newer designed ETT may carry? A comparison in cost of the old product, the 
MK, to the newer KCHVLPMC tube was performed in 2010 at the facility where the CP was 
conducted (B. Seward, personal communication, January 13, 2012). When compared in 2013 
using hypothetically similar prices; the MK costing approximately two dollars per tube and the 
KCHVLPMC model costing two dollars and forty cents per tube. The number of ventilator days 
used was 821 days which was the number of days reported for 2012. The MK tube would have 
had a cost of $1641.00 dollars. Comparatively, the KCHVLPMC model for the same 821 
ventilator days costs $2070.00 dollars, a cost difference of $429.00 dollars. The cost of one VAP 
is estimated to be $5000 to $25,000 for one incident (Bird et al., 2010). The cost of preventing 
one VAP would clearly support an investment in the newer designed ETT. Zolfaghan and 
Wyncoll (2011) states if a newer intervention, like implementing the use of the newly designed 
Kimberly Clark ETT, reduces the VAP rate by a mere one percent, it would be worth the change 
in practice. The staff involved with intubations required no additional training. Therefore, there 
was no additional cost incurred in training or educating the departments or personnel, who were 
responsible for these types of patients. The cost of orienting newer ICU employees in caring for 
the MV Adult ICU patient remains included in the six week Critical Care Course (CCC) that all
NR706C_PageJo_wk8CAPSTONE PROJECT 14
new graduate nurses must attend before working in the unit environment. The course costs 
approximately $5700 and that covers approximately 8 participants per class.
When a nurse with prior experience or working at the facility where the CP was conducted 
accepts a nursing position in the ICU they may choose to take certain topics of the CCC. All are 
encouraged to take the pulmonary and cardiovascular topics, and must attend the 16 hour hands- 
on skill lab. Each topic alone will cost the hospital approximately $900 and the pulmonary topic 
does include care of the MV adult ICU. The skill lab costs approximately $650 for both days. 
Again, when compared to the cost of one VAP incidence these expenses are clearly worth the 
investment.
Mission/Vision/Goals
A mission statement was essential in the CP, and it is short and concise and still remained a 
simple thought, it was one that kept the mission alive and possible, and the focus meets the 
present, as well as future strategic plans (Ward, 2013). The mission of the CP was “to create and 
facilitate health care to the people being served” and that included all adult ICU patients 
requiring intubation while in ICU.
A vision statement was also created and it is concise and easy to remember, it continued to 
drive the goals and objectives needed to achieve the vision (Barker, 1992). The vision of the CP 
was “to restore to health caringly, educate resourcefully, and to constantly give rise to better 
patient care outcomes” through the use of EBP interventions. From time to time it was recapped 
and that kept the staff where the CP was conducted engaged in the vision, and promoted the main 
objective, which was and is to provide EBP care.
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The most important goal and objective of the CP was to determine if, along with current VAP 
prevention strategies, did the use of the newer designed ETT like the KCHVLPMC reduce this 
pneumonia, and did it provide a better patient care outcome. The common core ethical, personal, 
and professional values of the CP included conducting everything concerned with the project, 
through the endorsement of accountability, advocacy for the patients involved , integrity, respect, 
honesty, resourcefulness, beneficence, justice, caring, dedication, collaboration with others, 
compassion, and also embraced the provisions needed for the delivery of excellent healthcare 
services to the MV patient population.
Process/Outcomes Objectives
The main objectives were to distinguish if there was a decrease in VAP incidence with the 
KCHVLP ETT compared to the MK tube, thus resulting in decreased mortality, ventilator days, 
VAP incidence, infections, and cost, and to conclude if there was increased compliance to the 
VB and improved patient care outcomes. Outcome plans were to, evaluate equally in 12 month 
periods the KCHVLPMC ETT and MK tube on VAP incidence, VB compliance, ventilator days, 
and VAP incidence in the comparative periods. The ventilator benchmark for year January 2011 
to December 2011 when the MK tube was used for intubations in ICU was, number of VAP 
cases equal one, the number of ventilator days equals 580 (C. Parker, personal communication, 
March 1, 2013) These are the benchmarks being compared for year January 2012 to December
2012 when the KCHVLPMC tube was put into practice for all adult intubations in ICU. VAP 
where VAP cases equal two, and the number of ventilator days equals 821(C. Parker, personal 
communication, March 1, 2013).
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As stated, the focus of the CP was to identify the measurable outcomes for the above selected 
study population and determine if the goals were met. There are four main outcomes 
measurements to be achieved.
First, assessment of the outcome measurement on the impact of product implementation using 
the KCHVLPMC ETT for all adult patients in ICU requiring intubations, compared to the MK 
ETT on the reduction in VAP incidence. The first and primary outcome measure will be the 
relationship between the KCHVLPMC ETT in a 12 month period compared to the MK ETT in a 
comparable period in VAP incidence in the ICU at the facility where the CP was conducted. 
Second, assessing the compliance of all current VAP prevention strategies, which includes the 
VB implementation at the time of intubation and data collected on the ventilator QI form by the 
nursing staff. Third, look at the number of ventilator days in a 12 month period of time January, 
2011 to December, 2011 for the MK ETT and January, 2012 when the KCHVLPMC ETT was 
first implemented and the MK tube was removed from use to December, 2012. Fourth, the 
number of VAP incidence in the same time period January, 2011 to December, 2011, and 
January, 2012 through December, 2012. With exception of the ETT designs, the EBP strategies 
to prevent VAP for both ETT time frames have remained the same such as: basic infection 
control methods like excellent hand hygiene adherence, proper patient positioning that included 
head of bed elevated greater than 30 degrees at all times, effective mouth care every two hours 
with chlorahexadine teeth brushing every four hours, early removal of the ETT that includes 
daily sedation breaks, and daily weaning parameters, and considering the use of the newer 
designed ETT currently available and showing evidence of VAP incidence reduction.
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Logic Model
The intent of the evaluation plan on the CP outcomes was to visibly give detail to the 
underlying association of relationships and a clear understanding of what is necessary to 
ascertain the indifferent association of relationships. Even before the study on outcomes was 
planned, the examiner needed to have a visual and mental picture of the outcomes of interest, and 
the impact it will have on the associated relationships. The use of a conceptual model provided a 
visual clear detail of association with the practice problem concerns, clinical factors, prevention 
strategies, and outcomes (Kane, & Radosevich, 2011). Zaccagnini and White (2011) provided 
the conceptual model used in the CP and the example of a logic model that was the expected 
model by Regis University to be used in the project (Appendix B). This is an example of the 
DNP process that did best guide the CP and was designed during the planning phase of the 
project for evaluation purposes. The logic model contains the inputs outputs and outcomes all 
parts found in most models and contains the components necessary for connecting the difference 
parts of the project logically together thus providing an illustration of the progression that the 
project did and was expected to take.
Appropriate for Objectives and Research Design
The research design was a retrospective data collection method. The data was obtained from 
the CP conducting facility soon after the IRB of the hospital, and Regis University had approved 
such. The project was officially declared exempt status by the University on February 18, 2013. 
The evaluation plan was appropriate for the CP objectives stated above, and the methodology 
design; a descriptive analysis of retrospective data comparison obtained from the 20 bed mixed 
ICU. The set period of time January 1, 2011 to December 31, 2011 for the MK ETT and January
1, 2012 to December 31, 2012 for the KCHVLPMC ETT.
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To aid in data collection a example of a ventilator QI compliance chart indicating adherence 
to the VB was made available by the facility where the CP was conducted. (Appendix C). 
Compliance was documented as a yes or no for each ventilator (QI). Compliance calculations 
were summarized monthly and data was provided monthly during the nursing staff meeting by 
the CCU Nurse Manager who compiled the data for the ventilator QI. Compliance on the use of 
the adopted KCHVLPMC ETT was compiled by the Manager of the Respiratory Care 
Department and shared at the monthly VAP committee meeting.
Time Frame
The timeframe for the CP started in September 2011 in the DNP program course Theoretical 
Application for Doctoral Nursing Practice, where the practice issue of concern, the problem 
identification, PICO format was established and the final question to be investigated and 
answered was created. Clinical rotations started in January 2012 and were completed this April
2013 where a total of 900 hours were performed in the Application to Practice Clinical Hours 
courses required in the DNP program. In December 2012 the request for exempt status was 
submitted to the Regis University IRB as part of the DNP Capstone Project course completed 
that fall semester, and it was approved in February 2013 in spring DNP Capstone Project course. 
Approval for data collection was granted in December 2012 by the IRB at the facility where the 
CP was conducted. Data collection began in February 2013 and is now completed. The 
timeframe for obtaining the retrospective data collection was from February 27, 2013 until May 
31, 2013. The data was collected on time and tabulated with results known as of July 4th, 2013 
(Appendix D).
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Budget and Resources
The budget issues associated with this CP were approximately $37,000 which is based on 
another person conducting such work without being in a DNP program CP. Wages for the 900 
hours of clinical alone would have been $36,000 based on a $40.00 an hour wage. Another 
$1000 in expenses was allotted for travel, meals, library use, stationary and computer use, along 
with the installation of the SPSS statistical tools, and extra reference books used to achieve the 
CP literature reviews and additional academic information. The facility where the CP was 
conducted has already removed the MK ETT from service availability, and had purchased and 
placed the KCHVLPMC ETT into service availability prior to the project starting. The hospital 
had completed a VAP timeline and the official change was initiated January 2011. There was no 
additional education required for the implementation of this product. There were no additional 
funding sources attached to this CP (Appendix E).
Population/Sampling Parameters
The population of interest for the CP came from a 20 bed ICU and a 150 bed acute care 
facility. The population was all adult 18 years and older patients who were intubated during their 
stay in ICU. Cases of VAP incidences were identified using the 2011 CDC criteria. Cases of 
incidence were also scrutinized by the ID Nursing Department, VAP committee members and 
the CNO of this facility. The plan for analysis was based on the dependent variable VAP 
incidence, defined as: pneumonia in an adult patient intubated in ICU, and ventilated at the time 
of or within 48 hours before the onset of the event. The MV patient had to present with at least 
one of the following: fever > 100.4 degrees Fahrenheit with no other cause, leukopenia (<4000 
WBC/mm3) or leukocytosis (> 12,000 WBC/mm3), and at least two of the following: new onset 
of purulent sputum, or changes in character of sputum, or an increase in respiratory secretion
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needing more suctioning via the ETT or new onset of cough, dyspnea, tachypnea, or rales, or 
worse gas exchange, oxygen (O2) desaturation, or increased demand for O2 or increased demand 
for ventilator (Center for Disease Control and Prevention, 2011). Chest X-rays were obtained 
and a newly developed infiltrate suspecting a recently developed pneumonia was given 
consideration if the case was deemed a VAP. The new guidelines for a VAP according to the 
CDC as of 2013 were not included in this definition but were compared on the cases deemed a 
VAP from January 2012 to December 2012. The rate of VAP was defined as the number of VAP 
cases per/year per/1000 ventilator days. Ventilator days were based on the number of days the 
patient used the ventilator prior to extubation. Compliance of the VB was done randomly by the 
nursing staff, and was conducted daily as part of the author’s clinical application during the DNP 
Application to Practice courses. As stated previously, compliance was documented as a yes or no 
on each ventilator (QI) completed and summarized monthly and the results provided monthly 
during the nursing staff meetings.
Setting is Appropriate for EBP Project
The setting is appropriate for an EBP project based on the patient population of interest, the 
final question to be answered, and the evidence gathered (Zaccagnini & White, 2011). There are 
four outcomes to be achieved, first, the relationship between the KCHVLPMC ETT in a 12 
month period compared to the MK ETT in a comparable period on VAP incidence. Second, 
assess compliance of VAP prevention strategies, included in the VB from ventilator QI data 
during both time periods of ETT s use. Third, calculate number of ventilator days over the same 
periods of time. And fourth, calculate number of VAP incidence in the same time periods.
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EBP Design Methodology and Measurements Provided
The statistical software SPSS program was used in the predictive analysis aspect of the CP. 
SPSS is a highly recognized computer program when calculating statistical data and predicting 
outcomes (Polit. 2010). The two-sample t-tests using a probability value (p - value) based on 
0.05 was a feature used on the SPSS computer program and was conducted along with the two- 
sample t-tests for all data analysis. Ventilator QI and VAP incidence data was provided by the 
Nurse Manager of the ICU during the time periods of both ETTs.
The two-sample t-test was used on three of the outcomes to indicate the mean of two normal 
populations are really equal. A p-value of 0.05 results was used to support there was or was not a 
difference in the two comparative ETTs. A p-value < than 0.05, indicates there was less 
probability that the ETTs are the same in decreasing VAP. A p-value > than 0.05 p-value 
indicates a greater probability exist that they are the same. This demonstrates there were no 
difference in the ETTs and VAP reduction. Data collection results of ventilator QI will not be 
shown as both 12 month time periods remained at 100%. Therefore a two sample t-test was not 
conducted. VAP rate/1000 ventilator days were provided by the ID nurse of the CP conducting 
facility.
Protection of Human Rights procedure complete
In August 2012 a Collaborative Institution Training Initiative (CITI) course was completed 
and a copy of the completion was provided to the Regis University IRB along with an 
application for exempt status to conduct the CP (Appendix F). Protection of human rights 
procedure was completed and approved by the Regis University IRB who granted exempt status 
in February 2013, and the IRB at the facility where the CP was conducted granted approval for 
retrospective data collection (Appendices G and H). There was no harm that could come to the
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patients the data was collected on as a result of this CP and there was no breach of 
confidentiality. The source of the data in this CP is also available publically. All data collected 
was retrospective in nature. In addition, all data provided and collected remained secure within 
the facility where the CP was conducted in a locked cabinet or password protected computer. 
Equally important, along with data collection, treatment procedures, and protocols discussed in 
this project plan and evaluation section, as stated earlier there were no identified issues with 
feasibility, risks or unintended consequences.
Instrumentation Reliability/Validity and Intended Statistics
For reliability of data, a confidence interval set at a 95% range was implemented. This 
indicates the data falls between two standard deviations from the mean which is therefore closely 
banded and signifies no abnormalities. For validity the data collection was validated based on the 
outcomes results.
Data Collection and Treatment Procedure
This author collected data on VAP rates for years 2011and 2012 on March 1, 2013 from the 
ID nurse of the facility where the CP was conducted. In addition the ID nurse provided the 
ventilator days for 2011 and 2012. The CCU nurse manager provided the ventilator QI data. The 
MK tube was in practice in 2011, and one VAP incidence was reported. The KCHVLPMC ETT 
was in practice in 2012, and two VAP incidences were reported in that year. All VAP incidences 
were on adult ICU patients intubated and MV while hospitalized in the ICU. After the data was 
provided it was used solely for the purpose of the CP and has since been returned to the facility 
where the CP was completed, and will remain secure within that facility.
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Project Findings and Results
Organized by Objectives
The main goal of the CP was to provide the best EBP interventions possible and assure the 
most favorable outcome to the intubated and MV adult ICU patient was achieved.
The main objectives were to first, determine if there are decreased VAPs with the KC ETT 
compared to the MK; second, did compliance to the VB remain 100%; and third, calculate the 
number of ventilator days over the same time period, and fourth, calculate the number of VAP 
incidence in the same time period. The outcome plans were to first, evaluate equally the 
relationship between the KCHVLPMC ETT in a 12 month period compared to the MK ETT in a 
comparable period on VAP incidence. Second, assess compliance of VAP prevention strategies, 
which included the VB from the ventilator QI data during both time periods of ETT use. Third, 
calculate the number of ventilator days over the same periods of time. Fourth, calculate the 
number of VAP incidence in the same time periods.
Key Elements and Instrumentation Findings and Statistical Data/Reliability of Findings
The methodologies applied on the retrospective CP outcome findings and results were the use 
of the SPSS program used for the predictive analysis aspect of the project. To support the 
validity of the findings this included the application of the two-sample t-test, along with a 
probability value (p value) based on 0.05, and the data results were tabulated on the SPSS 
program. In addition, the ventilator QI and VAP incidence data were provided by the nurse 
manager of CCU during the time periods of both ETTs, and was confirmed by the ID department 
coordinator. Equally important, the confidence interval of 95% was used to aid in the analysis, 
and supported the reliability of the outcome findings.
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Results Discussed According to EBP
The four main objective outcome plans project findings and results arranged in a question format
Outcome 1): was the number of VAPs different with the KC ETT compared to the 
MK?
Outcome results using the two sample t-test in evaluating equally the twelve month periods 
the KC and MK showed that there was no significant difference between the two tubes and the 
number of VAPs/1000 ventilator days, and based on the 95% confidence interval (CI), and the p  
value of (p = 0.67). The two tubes showed also that there was no significant difference in the 
patient care outcomes.
Outcome 2): Did compliance to the VB remain 100%?
Outcome results on the evaluation of the VB compliance shows that the bundle compliance
remained at 100% for both twelve month time periods. Therefore, a two sample t-test was not
conducted because the standard deviation is zero for both years, there was 100% compliance
year one and year two.
Outcome 3): Was the number of ventilator days different during the two time 
periods?
Outcome results on the number of ventilator days using the two sample t-test revealed there 
was a significant difference between the numbers of ventilator days for the two periods, the MK 
year 2011 is 580 ventilator days, and the KC year 2012 is 821 ventilator days. This was based on 
a CI of 95% and a p-value of (p  = 0.02). The results may have been different given more data 
from previous years. Typically a two sample t-test is used for larger data sets that allow for more 
variation in the data. The facility where the data was collected reported in 2012 the ventilator 
days of 821 was the highest recorded data point in their measured history. In addition, the nurse 
manager of CCU when asked if there was possibly a huge difference in the patient days for 2011
and 2012, offered data that revealed there were approximately 3720 patient days in 2011, 
whereas the patient days for 2012 were approximately 4660; a difference of approximately 900 
more patient days in that year (B. Seward, personal communication, July 1st 2013). The rate ratio 
was about the same between the two groups 580/3720 is 0.155 for 2011, and 821/4660 is 0.176. 
So the occurrence of MV patients between 2011 and 2012 was really not that huge of a 
difference.
Outcome 4): Was the VAP incidence different during the two periods
Outcome results on the number of VAP incidence for the two time periods January, 2011 to 
December, 2011 and January, 2012 to December, 2012. There is no significant difference 
between the two one year periods, based on the 95% confidence interval (CI), the p value of (p  = 
0.67); the VAP rate/1000 ventilator days was 1.7 for the 2011 period, and was 2.4 for the 2012 
period. This outcome measured the difference in the VAP incidence between the two one year 
periods. If both tubes were used at the same time during both years, there could have been a 
significant difference between the two tubes. Also, outcome number one and outcome number 
four have the same results because of the use of the different ETTs during the two one year 
periods. Again if both tubes were used at the same time the results may be different.
The final question is:
In adult ICU patients undergoing oral intubation while hospitalized in ICU, do patients who 
are orally intubated with the KCHVLPMC ETT have fewer VAP’s than those who are intubated 
with other commercially designed High Volume Low Pressure ETTs like the MK? From a 
statistical standpoint based on outcome number one, it indicated there is no significant difference 
between the two tubes and the number of VAPs/1000 ventilator days, based on the 95% 
confidence interval (CI), and the resulted (p = 0.67). p value. However from a clinical aspect the 
increase in ventilator days in 2012, the reported increase in CCU patient days, along with some
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reported staffing concerns and the credible literature support for the newer designed 
KCHVLPMC ETT, it is worth stating that along with these findings, perhaps a longer study 
would change outcome number one differently. Therefore, it is also worth seriously considering 
increasing the length of the data collection in another future study on this same subject of 
concern.
Limitations, Recommendations, and Implications for Change
Limitations
There are several limitations identified in the CP. First, this was a small snapshot of two equal 
12 month periods where retrospective data was obtained to determine if the design of the KC 
ETT was better at reducing VAP than the replaced MK ETT. If the time periods would have 
been possible over a longer period of time, it may have made a significant difference. Yet in 
prior years when the MK ETT was the main tube used for intubations, there were years when the 
VAP rates were higher than the reported two incidences during the 2012 calendar year. Add to 
this, the patient days in ICU for year 2011 when the MK was in place there were approximately 
3720 days, and in 2012 when the KC was being used, the patient days were approximately 4660 
days. Although this data was not requested as part of the CP retrospective data provided by the 
facility where the project was conducted it was made available and was recognized as a possible 
element in the matter. Equally important, both patients who did develop VAP had underlying 
predisposing issues, and the two pneumonias were based on the old CDC criteria that included 
the MV patient’s temperature graph, the daily complete blood count (CBC), the sputum culture 
results, and the daily chest X-ray (CDC, 2012). These complex cases had a potential pneumonia 
diagnosis prior to intubation, which made prevention difficult. However VAP was detected early 
and appropriate antibiotic therapies were initiated. The first case was a patient admitted with
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acute respiratory failure (ARF) due to a trauma incident several days earlier, and suffered 
multiple broken ribs and was diagnosed with bilateral pulmonary emboli, pneumonia, and had a 
reported possible aspiration due to the presence of a possible bowel obstruction which was 
associated with the use of a pain medication given while at home and prior to admission. The 
second case arrived in the emergency room with ARF and that day failed multiple attempts on Bi 
PAP to hopefully prevent needing intubated, and also had an underlying pneumonia and possible 
aspiration prior to admission. These two cases also failed the attempts taken to keep them from 
needing further ventilator support in the form of intubation and MV in the first place. Every 
possible early intervention and VAP prevention strategy was adhered to, but in spite of this a 
VAP did occur. Both cases also required multiple procedures and tests were performed in other 
departments and required these patients be in the flat position during the time of the tests being 
performed. There are always going to be cases like these that carry such high risk factors, but 
hopefully more can be learned as further research into the benefit the newer designed ETT can 
play in the prevention of VAP is conducted. Nonetheless there remains a growing want to reduce 
VAP, and a growing need to do so, from both the customer/patient and the healthcare industries 
as a whole.
Yet another identified limitation during the CP data collection timeframe was that the hospital 
where the data was obtained went through a merger with another healthcare organization. 
Although this had no impact on the CP, it did have an impact on the organization as a whole 
where the project was being conducted. Sorting through the merger process generated higher 
than average stress and anxiety levels within the healthcare staff. There was a multitude of 
staffing issues occurring at the same time leaving some unfilled job vacancies. It was during this 
time period that both VAP incidences occurred. These variables can lead to an unpredictably
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higher nursing workload, and can contribute to higher than usual job dissatisfaction. It is well 
documented these types of issues can show the way for increased HAIs like VAP to occur, and 
augments job frustration levels (Aiken, et al., 2009).
Recommendations
Based on the findings of the CP, the main recommendations for practice changes are as 
follows. First, continue a multifaceted VAP prevention approach that includes continuous 
compliance to VB protocols as stated earlier, along with pharmacological antibiotic support and 
other general measures such as early extubation, aspiration prevention, and decontamination 
strategies as simple as proper hand hygiene each time, every time, by everybody. In addition, a 
multidisciplinary approach that includes continuous education and daily ventilator QI, along with 
further investigation into newer technologies such as the design of the ETT to prevent 
contamination and aspiration in the MV patient. Second, continue to use the KCHVLPMC ETT 
for intubations and MV longer than 48 hours. Based on the outcome of the retrospective 
statistical data where the results of the two sample t-test showed no significant difference in VAP 
rates between the MK and the KC tubes, there is really no strong evidence against the utilization 
of this tube in the prevention of VAP, and there is sound evidence as stated in the literature 
review in supporting the use of this ETT design. In addition, based on all the statistical outcomes 
of the CP, in the future the findings from this project will be pursued further. From a clinical 
standpoint, strict adherence to the VB and other prevention strategies will now include daily 
surveillance and monitoring of the intubated ICU adult patient starting day one of MV, and 
consist of observation and collection of the patient’s positive end expiratory pressure (PEEP) and 
fraction of inspired oxygen (FiO2) levels in hope of recognizing early indications of a developing 
ventilator associated event (VAE), as defined by the CDC (CDC, 2012).
NR706C_PageJo_wk8CAPSTONE PROJECT 29
The implication for change requires putting evidence into practice when things that work are 
recognized as such. Once areas for improvement are recognized it is essential standards of care, 
policies, and procedures to prevent infections such as a VAP must be developed and strictly 
supported and adhered to by all levels of the organization, because preventing HAIs is the 
responsibility of every employee of the organization.
A multifaceted, multidisciplinary, and multi-professional approach is paramount to move any 
initiatives forward. It should start with education and reinforcement, and getting all staff 
involved which may call for hospital-wide reporting of HAI rates and their types. Barriers to 
change must be anticipated and determined how they will be dealt with. Providing adequate 
nursing and respiratory staff is very important; and are essential tools to assure the delivery of 
high quality care to the MV patient. In addition, provide adequate supplies and make them 
readily available to promote adherence to VAP prevention. Do daily QI monitoring on all MV 
patients, and perform and document daily surveillance and monitoring of the PEEP and FiO2 
levels starting day one of MV. Equally important, report adherence to the VB protocol and VAP 
rates monthly at nursing staff meetings. In addition continue to support the utilization of the KC 
ETT for intubation expected to be longer than 48 hours until further evidence indicates there is a 
better ETT available that deceases VAP incidences. Last, continue to conduct frequent literature 
reviews on the subject of VAP prevention and the use the newer designed ETTs in preventing 
this HAI, to assure that the best evidence based practices are made available to the adult ICU 
MV patient population.
Summary
The CP was the final step of the DNP program. It reflected a demonstration of synthesis and 
mastery of an advanced subject within the practice of nursing by the student completing their
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final academic steps (Zaccagnini & White, 2011). The purpose of a CP was to improve a practice 
and or a patient care outcome and also set the tone for continuous improvement through EBP 
interventions (Zaccagnini & White, 2011).
The purpose of this paper was to provide in writing the CPs problem recognition and 
definition, review of evidence, project plan and evaluation, project findings and results, 
limitation, recommendations, and implications for change, and did the use of newer designed 
ETT like the polyurethane KCHVLPMC ultrathin tube result in a decrease in VAP rates 
compared to other HVLP like the MK ETT designs. Further investigation into the role the ETT 
design can play in the reduction of a VAP was pursued. From starting out with the practice issue 
of concern, and using PICO; a PICO statement was created, and data was collected that 
supported no changes in practice from the current use of the KCHVLPMC ETT was necessary. 
The MV critically ill ICU patient is at high risk for developing VAP, and it is evident that better 
patient care outcomes can be achieved using a multifaceted prevention strategy approach that 
includes the use of the KCHVLP ETT. The final question was answered, in adult 18 years and 
older patients undergoing oral intubation while hospitalized in ICU, do patients who are orally 
intubated with the KCHVLPMC ETT have fewer VAP’s than those who are intubated with the 
MK ETT? The answer was that there was no significant difference in the VAP incidence when 
the adult patient in ICU was intubated and kept on mechanical ventilation for longer than 48 
hours with either ETT the KC or the MK.
VAP is a pervasive and costly HAI greatly associated with the use of instrumentation to 
maintain the airway and the ETT selected to achieve ventilated passage. Even though many 
factors contribute to the development of a VAP, a multifaceted prevention approach seems to 
still be the best strategy. The CP was just a small snapshot comparing two ETTs effectiveness
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against VAP and it is apparent from the systematic review that larger RCT before any definitive 
practice change can be recommended must be accomplished. It is evident further investigation 
into the role the ETT and other prevention strategies plays in the reduction of a VAP must 
continue to be pursued.
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Capstone in 
the logic that 
simple 
prevention 
strategies 
done
consistently 
can reduce
VAP
incidence and 
be conducted 
at minimal 
cost. It is 
done 
routinely 
anyways why 
not always 
prior to 
position 
changes.
M odifying
endotracheal
tubes to
prevent
ventilator-
associated
pneumonia,
Current
opinion in
infectious
diseases, 24:
157-162.
Coppa
doro,
A.,
Berra, 
L., & 
Bigatel 
lo, L., 
(2011)
CINALH: 
Aspiration 
pneumonia 
; biofilm; 
EET 
coating; 
ETT cuff; 
VAP
Retrosp
ective
literatur
e
review
Level-II Looking at 
m odified ETT 
designs and the 
im pact on VAP 
reduction 
incidence.
Cardiac 
surgical pt; 
pts
intubated 
for > than 
24 hrs;
A  Phase 1/11 
clinical trial on 
cardiac pts and a 
phase 111 
randomized 
multicenter trial 
on 1500 pt 
intubated > than 
24 hrs. with an 
antimicrobial- 
coated ETT. A 
study on ETT 
with SSD in over 
700 cardiac surg. 
Cases, and in a 
m ulticentered 
trial o f  333 pts 
using the SSD 
ETT. In a pilot 
clinical trial o f 
134 cardiac 
surgical pts on 
the polyurethane 
microcuff.
Antim icrobial ETT- 
no organized 
bacterial biofilm  and 
lower colonization 
rates. SSD- no 
benefit seen in the 
use o f  this ETT in 
fact possible 
tracheal dam age can 
occur. Poly ETT- 
protected against 
early onset o f  a 
VAP and an 
association to 
reduction in 
antibiotic use. No 
clinical data 
available on the 
HVLP Poly ETT.
The use o f  modified 
ETT regardless o f 
the design have not 
decreased VAP 
incidence, shorter 
vent days, or higher 
survival rate.
Good study data 
strongly supported 
by experts like 
Blunt, Deem,
Kollef, Kolobow, 
Lorente, and Rello, 
P t population could 
have been identified 
specifically in 
categories o f  > than 
48 hr M V and < 
than 48 hours. Also 
w ere they ICU adult 
pts etc.
None
listed
This article 
definitely 
support the 
PICO 
healthcare 
problem  o f 
how  best to 
prevent VAPs 
and the need 
for further 
research into 
the impact 
newer 
designed 
ET T’s can 
have on VAP 
reduction.
Novel Coppa PUBMED: System Level-I Consideration M ainly Literature review Before and after M any factors STR: The authors None I liked the
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preventive doro,
strategies A.,
for Bittner
ventilator - , E., &
associated Berra,
pneumonia, L.
Critical (2012)
care,
16(210), 1-
VAP;
prevention
atic
Review 
o f  most 
relevan 
t
studies 
support 
ing the 
use o f 
novel
o f  novel 
preventive 
strategies for 
VAP prevention 
that have 
clinical studies 
supporting their 
benefits.
A dult ICU 
intubated 
M V pts
o f  credible 
studies done on 
VAP prevention 
strategies.
study H ead o f  bed, 
oral care with 
chlorhexidine gel, 
sedation vacation 
and vent weaning 
protocols reduced 
VAP rate. Early 
tracheotomy 
procedure in a RCT 
did not reduce VAP 
incidence. RCT 
using pneumatic 
devices did not 
reduce VAP rate. 
RCT o f  SSD ETT 
reduced VAP 
incidence. R CT of 
silver-coated ETT 
compared to 
standard ETT VAP 
rates w ere lower. 
Retrospective assess 
with the
polyurethane tube vs 
a standard ETT 
showed a reduction 
in VAP rates. M eta­
analysis o f  RCT 
associated with the 
use o f  probiotics 
reported a reduction 
in VAP rates.
contribute to the 
cause o f VAP. VAP 
prevention strategies 
being used today are 
still not creating a 
Zero VAP 
prevention. Among 
other prevention 
strategies that need 
to  be evaluated is 
the use o f  modified 
ETT such as SSD, 
coated tubes and 
alternative cuff 
designs. Pt 
positioning, kinetic 
therapy, and 
probiotic
adm inistration must 
be furthered studied 
in this on-going 
battle to reduce 
VAP incidence.
used w ell selected 
studies for their 
systematic review. 
LIM : There is room 
for bias against 
smaller RCT.
reported article and the 
author’s 
conclusion 
that were 
based on 
credible 
studies. I fully 
agree that 
there m ust be 
on-going 
research 
efforts to find 
other
prevention 
strategies to 
reduce the 
incidence o f 
VAP. This is 
why I selected 
VAP
prevention as 
the PICO 
healthcare 
issue.
Estimating
the
proportion
of
healthcare-
associated
infections
that are
reasonably
preventable
and the
related
mortality
and costs.
Infection
Control And
Hospital
Epidemiolo
gy, 32(2),
101-114.
Craig,
A.,
M itche 
ll, M ., 
Doshi, 
J.,
Agarw 
al, R., 
Willia 
ms, K., 
&
Brenna
n, P., 
(2011)
PUBMED:
Estimating
the
proportion 
o f  HAI
System
atic
Review
and
figures
from
the
Nationa
l
Nosoco
mial
Infectio
ns
Surveill 
ance 
(NNIS) 
System 
s. The 
Nationa 
l
Hospita
l
D ischar
ge
Survey 
and the 
Americ 
an
Hospita
Level-I-
Systema
tic
Review
To estimate the 
proportion o f 
HAI in the U.S. 
hospitals that 
are preventable 
and has a high 
mortality and 
cost factor.
Varied H AI Incidence, 
Associated 
M ortality and 
Risk Reduction. 
Systematic 
Review of 
interventions to 
reduce HAI, and 
ranges o f 
preventable risk 
reductions, and 
systematic 
review o f  cost 
factors
As many as 55% o f 
VAP may be 
preventable with 
current EBP 
strategies VAP 
carries a high 
mortalityand 
prevention can save 
considerable costs.
Even with 
preventable 
strategies for VAP a 
zero VAP incidence 
may not be 
attainable. Each pt 
carries a set o f 
unique risk factors. 
M ore research is 
needed on 
prevention o f  HAI.
The strength and 
limitations w ere not 
listed out but it is 
obvious to 
determine that just 
doing s systematic 
review would lend 
validity to the data. 
On the other hand 
there is room  for 
uncertainly in the 
estimates on the 
proportion o f  HAI, 
there is also not a 
specific population 
group, and what 
determine a 
preventable HAI 
death w hen there 
could be other risk 
factors not known. 
Cost estimates 
could have been 
collected from  fair 
to poor designs that 
the study was 
concluded on
None
listed
H AI nay 
never be 
totally 
preventable 
but with EBP 
strategies we 
can hope to 
reduce these 
incidences.
& II
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l
Associa
tion.
Prevention Craven PUBMED: Syste m Level-I- Prevention o f Adults who Retrospective VAP increases A m ultidisciplinary Star: Craven is the No I see Craven
ventilator s, D., antibiotics; atic Systema VAP and are data provided possible mortality prevention team head o f  the ID source as a
associated (2006) evidence- Review tic im plem entation mechanicall from  resources 20 to 70 % in approach w ill led by departm ent at listed. Champion
pneumonia based data; that Review o f cost-effective y like the IHI, and medical ICU; costs a Cham pion is Lahey Clinic h im self
in adult guidelines; conduc o f strategies and ventilated. RCT. estimated recom mended to M edical Ctr and has against VAP
sowing IH I=Instit ed data creditab investigating $40.000/case; and help set priorities, w ritten several incidences. I
seeds o f ution for compil le RCT, barriers to their accounts for approx benchmark goals, manuscripts on have read
change. H ealthcare ed from clinical im plem entation 25% o f  all ICU analyze data and VAP prevention he other articles
Chest, Improvem the studies s among infections and > sow seed for change is seen as an expert w ritten by
130(1), 251- ent; VAP review and facilities and than 50% o f that prom otes risk and seeks out other him. I have
260. ventilator focused experts healthcare antibiotic use. reduction. experts as w ell like also seen his
www.chestj associated on in the providers. Rello. Craven article's
ournal.org pneumonia 
; intensive 
care;
prevention
o f
hospital-
acquired
pneumonia
(HAP)
VAP
prevent
ion
strategi
es of
adult
populat
ions
and
emphas 
is on 
new 
concept 
s.
field. yearns to prevent 
VAP incidence and 
reduce occurrence 
using multiple 
strategies.
information 
used by other 
experts such 
as J. Rollo, 
M. Kollef, 
and M. 
B onten all 
experts in 
their own 
right on the 
subject o f 
VAP
prevention..
New Deem, PUBMED: Literatu Level-I- Pathogenesis o f ICU M ost data was See above. In M ores studies need Str: S. D eem  and No Once again
endotracheal S., & Systematic re Systema VAP and the patients; collected via a addition VAP to be conducted in a M. Treggiari are source these authors
tubes Treggi review of Review tice role that the size o f varied incidence are setting that affiliated with the listed references
designed to ari, multiple and Review ETT plays population quantitative expensive, and are reproduced the Anesthesia other experts
prevent M., well collecti along with varied. method. largely related to the actual clinical D epartm ent and like Rello,
ventilator- (2010) designed on o f recom mended Examples: A ETT. The situation that both are well Kollef, and
associated RCT. historic VAP prevention retrospective prevention strategies warrants intubation respected in the M iller. I agree
pneumonia: Keywords: al data strategies. study on 4543 pt w ill be most in the first place and Respiratory Care m ore research
do they nosocoial from at 59 U.S. effective when in context with a and Anesthesia into the
make a pneumonia the hospitals found multifaceted bundle approach to healthcare possible
difference. ; infection; articles mortality rate approach which prevent VAP. profession. The advantages of
Respiratory subglottis results was as high as includes infection article which was the ETT to
Care, 55(8), endotrache 29%. Cost for a prevention, proper compiled on a very prevent VAPs
1046-1055. al tube;
ventilator
associated
pneumonia
; VAP;
mortality;
morbidity.
VAP can be as 
high as
$48,500/case. A 
meta-analysis o f 
five studies on 
subglottis ETT 
reveals a 50% 
reduction inVAP 
incidence. A 
small RCT on 
cardiac surgery 
p t who were 
intubated with 
the polyurethane 
cuffed ETT like 
the KCHVLP 
ETT and the 
M allinckrodt 
ETT found that
positioning o f  pt, 
oral care, and early 
rem oval o f  the ETT 
regardless o f  the 
type. M ore research 
into intubation 
techniques and the 
effects o f  the newer 
designed ETTs.
good sources of 
data adds 
creditability to the 
findings which 
were multicenter, 
meta-analysis, and 
R CT sources. 
Limitations: No 
actual research was 
conducted by the 
authors.
m ust be done.
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VAP rate were 
reduced form 
5.5/100 to 
2.8/100 vent 
days. Another 
random ized trial 
com pared a 
polyurethane 
tube, a subglottis 
tube and a 
conventional 
tube and found a 
significant 
reduction in VAP 
from  the 
specialized tubes 
(22% vs 8%). 
M ore research is 
needed. 
A ntibacterial 
coated ETT that 
w ere in an 
experimental 
setting show 
little benefit to 
VAP prevention 
over the other 
ETTs and 
actually would 
cost more.
Strategies in Diego, PUBMED: Eviden Level-I- VAP prevention ICU Literature review The preventive The author found W ell reviewed Dr This one
the M ., & H ospital ce IIEvide clinically intubated based on EBP measures for VAP based on the based on the experts Restrepo article
prevention Restre acquired based nce - relevant and outcomes. No include four evidence related to on the subject o f was supports the
of ventilator po, M., pneumonia review based pharmacologica mechanicall pharm acological categories: (1) the pharmacologic VAP prevention. supporte need for more
associated ( , ICU- o f well l and no y ventilated M easures general measures, and Some o f  the d by the research on
pneumonia. 2011). related, literatur conduct pharmacologica patients. Evidence grade like infection nonpharm acologic literature was from National the prevention
Therapeutic preventive e ed l interventions and control (K ollef therapeutic as far back as 1994 Institute o f  VAP
A dvances in measures systema to prevent VAP. Pharmacological 1999) (2) early maneuvers involved but still very of Health incidence. It
Respiratory ventilator tic Owing to the M easures extubation, (3) in the prevention o f pertinent today and was w ell done
disease, associate review im portance o f Evidence Grade. prevention o f VAP. Owing to the based on VAP rates National and the level
5(2), 131- pneumonia this condition Standard aspiration, high cost, morbidity, and incidence Heart,Lu o f  evidence
141. the precautions M easures such as and m ortality o f nationwide and ng and was very
im plem entation Level I, Oral daily interruption o f VAP, preventive current VAP Blood strong and
o f  preventive decontamination sedation and measures are prevention Institute. therefore
m easures is Level II, Hand pursuing a protocol param ount in the strategies.. creditable.
param ount in hygiene Level I for early extubation care o f  mechanically The PICO and
the care o f ,Selective are associated with ventilated patients. healthcare
mechanically digestive shorter duration o f There is evidence problem  for
ventilated decontamination mechanical that these measures the Capstone
patients. There Level II, S taff to ventilation [W ood et decrease mortality stalwartly
is evidence that patient ratio al. 2007;Horst et al. and improve reflect the
these measures Level II, Silver- 1998; K ollef et al. outcomes in the outcomes and
decrease the coated 1997; Saura et al. ICU,and include conclusion.
incidence o f endotracheal (4) decontamination. general measures,
VAP and tube Level I, Similarly, a early extubation,
improve Semi seated prospective clinical aspiration
outcomes in the position Level I, study o f  critically ill prevention, and
intensive care Daily sedation patients, who decontamination. A
unit. A breaks Level II, rem ained in the m ultidisciplinary
multidisciplinar A dequate semi seated position approach, continued
y approach, Endotracheal o f  30 degrees for the education, and
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continued 
education, and 
ventilator 
protocol are all 
essential.
43
cu ff pressure 
Level II, 
D rainage o f 
subglottic 
secretions Level 
II, Avoidance o f 
circuit
manipulation 
Level II, Early 
extubation Level 
1 Evidence 
Grade: Level I 
(high): evidence 
comes from  well- 
conducted, 
random ized 
controlled trials. 
Level II 
(moderate): 
evidence comes 
from  well- 
designed, 
controlled trials 
w ithout 
random ization 
(including cohort 
patient series and 
case_control 
studies) and 
systematic 
analysis not 
collected in a 
random ized 
fashion. Level III 
(low): evidence 
comes from  case 
studies and 
expert opinion.
first 24 hours o f 
mechanical 
ventilation, and had 
a lower incidence of 
VAP com pared with 
patients positioned 
at less than30 
degrees [K ollef et 
al. 1999], Several 
agents have been 
studied for oral 
decontamination. 
These include use o f 
chlorhexidine, and 
povidone iodine. It 
has failed to show 
any significant 
benefit over placebo 
in preventing VAP 
in a large 
random ized trial 
[K ollef et al. 2006], 
The association o f 
microaspiration with 
VAP is clearly 
established 
[Valencia et al.
2007; Craven and 
Steger, 1996; Valles 
et al. 1995; M ahul et 
al. 1992; Torres et al. 
1992], The 
incorporation o f  an 
ETT w ith an 
ultrathin 
polyurethane 
m embrane cuff (7 
mm com pared w ith 
50 mm in the 
conventional cuffs) 
that reduces the 
form ation o f 
channels and the 
escape o f  subglottic 
secretions to the 
distal airway has 
been used 
(Kimberly- 
ClarkM icrocuff_) 
[Dullenkopf et al. 
2003], W hen 
com pared with a 
conventional tube, 
this modality, in 
addition to the 
subglottic secretion 
drainage, had a 
significant decrease 
in the incidence o f 
early and delayed 
VAP [Lorente et al.
ventilator protocols 
ensure the 
im plem entation o f 
these measures. 
Future research will 
continue to 
investigate 
cost/benefit 
relationships, 
antibiotic resistance, 
as w ell as newer 
technologies to 
prevent
contamination and 
aspiration in in the 
mechanically 
ventilated pt.
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2007]. The 
incorporation o f  an 
ETT with a dorsal 
channel for 
subglottic secretion 
aspiration is 
recom mended as a 
preventive strategy 
when considering 
the high cost o f 
developing VAP, 
low risk, and proven 
benefit, especially in 
patients 
mechanically 
ventilated for more 
than 48 hours [Rello 
et al. 2002]. The 
pathophysiology o f 
VAP involves a 
secondary 
colonization o f  the 
upper respiratory 
tract by nosocomial 
pathogens, 
accumulation o f  se
Ventilator-
associated
pneumonia:
current
status and
future
recommend
ations,
Journal o f
Clinical
M onitoring
and
Comparing, 
(24), 161­
168.
Efrati,
S.,
Deutsc 
h, I., 
Anton 
elli,
M., 
Hocke 
y, P., 
Rozen 
blum, 
R., 
(2010)
CINAHL,
VAP,
pathogenes
is,
epidemiolo 
gy, clinical 
practice 
guidelines, 
prevention
technology
Update
d
review
o f
current
literatur
e
Level I- 
systema 
tic
review 
o f  well 
designe 
d RCT
Study aim  is to 
review the 
pathogenesis 
and
epidemiology 
and the current 
and future 
recom mendatio 
ns on VAP 
prevention 
strategies.
NA References from 
highly 
recognized 
experts on VAP 
prevention 
strategies like: 
Cook, Kollef, 
Lorente, Rello, to 
name a few.
Not cited in the 
article
Strong International 
and National 
recom m endation for 
more technological 
com bination o f 
solutions based on 
the ETT. Subglottis 
suctioning, 
optimizing ETT cuff 
pressure and 
ultrathin cu ff ETT 
designs.
Supportive 
evidence for the 
Capstone PICO  but 
nospecific 
identified ICU pt 
population or data 
from  RCT in the 
article; ju s t general 
good information.
None
listed
Strong 
support for 
the PICO  and 
identified 
healthcare 
problem 
w hich is VAP 
and w ay to 
prevent 
incidence.
Asking the 
right 
question. 
Journal o f 
Em ergency 
Medicine, 
33 (6), 571­
573.
Engber
g, S.,
&
Schlen
k, E., 
(2007)
Pubmed:
Keywords
EBP
asking the
right
questions
NA NA NA NA NA 0 0 NA No
source
listed
This was an 
informative 
article on 
asking the 
right PICO 
question to 
obtain the 
best outcome. 
This article 
was most 
helpful early 
on the EBP 
PICO
development.
Technology 
advances in 
endotracheal 
tubes or 
prevention 
o f  ventilator
Fernan 
dez, J., 
Levine 
, S., 
and 
Restre
MD
Consult’s
full-text
literature
database.
Technolog
Literatu
re
Review
Level I Review the 
literature 
regarding the 
recent advances 
in ETT tech. 
targeted at VAP
M /S ICU pt 
mechanicall 
y ventilated 
(M V) > 
than72 hrs, 
in Spain,
RCT results from 
1994 to 2010; 
RCT,
retrospective 
controlled, and 
prospective RC
M ost RCT revealed 
decreased VAP 
incidences. K ollef et 
al (2008) using the 
silver-coated EET 
cu ff concluded VAP
M ultiple prevention 
interventions such 
as ventilator bundles 
compliance and the 
use o f  newer ETT 
along with
RCT strongly 
supports the 
findings; the 
systematic review 
was done including 
highly recognized
None
noted
This is a 
strong article 
that supports 
the Capstone 
Project and 
places strong
NR706C_PageJo_wk8CAPST0NE PROJECT 45
associated 
pneumonia, 
Chest, 
142(1). M D 
Consult full- 
text
database.
DOI
10.1378/che 
st. 11-2420
po, M.,
(2012)
ic
Advances 
in EET for 
prevention
o f  VAP
prevention. France, 
China, The 
Netherlands 
and pt MV 
> than 48 
hrs, in 
China and 
France, 
cardiothora 
cic pt in 
ICU in the 
U.S. and 
Spain. 
Subglottis 
secretion 
devices 
(SSD ) and 
non SSD, 
Tapered 
ETTcuffs 
and
Polyvinylch 
loride cuff 
(PVC) cuff, 
Cylindrical 
ETT cuffs 
and PVC, 
Silver- 
coated ETT 
and non 
silver 
coated 
ETT.Sampl 
e sizes were 
from  18 pts 
Girou et al 
(2004) to 
1503
ptK ollef et
as (2008).
studies. trends w ere delayed 
and a reduction in 
VAP incidence with 
shorter term ed MV. 
ETT colonization o f 
pathogens play a 
key role in VAP 
incidence, The 
newer designed ETT 
with SSD, 
polyurethane cuffs, 
cylindrical tapered 
and silver-coated 
ETTs show promise 
but more studies 
must be completed 
and therefore cost- 
effectiveness o f 
im plem entation o f 
these newer ETT 
designed m ust be 
given consideration.
pharm acological 
and non
pharm acological 
strategies must be 
studied further.
data trials for 1994 
to current.
evidence on 
the need for 
further 
research into 
the prevention 
role newer 
designed ETT 
along with 
other VAP 
prevention 
strategies play 
in VAP 
reduction.
Are
specialized
endotracheal
tubes and
heat-and-
moisture
exchangers
cost
effective in
preventing
ventilator-
associated
pneumonia?
Respiratory
care, 55(2),
184-197.
Gentil
e, M., 
&
Siobal,
M.,
(2010)
PUBMED:
VAP
prevention 
; heat-and
exchange; 
polyuretha 
ne cuff; 
endotrache 
al tube; 
silver- 
coated; 
nosocomia 
l
pneumonia
Literatu
re
Review
o f RCT
and
meta-
analysi
s
Level-I VAP prevention 
is a multi-facet 
priority o f  the 
intensive care 
team  and can 
include the use 
o f  specialized 
airways and 
heat-and -  
moisture.
No
specifics 
found in the 
article
Data retrieved 
from  studies:
Six RCT and a 
meta-analysis o f 
five studies 
found that SSD 
found that this 
type o f  ETT 
reduced VAP by 
nearly ha lf (risk 
ratio o.51,
95% CI 0.37­
0.71) in a 
heterogeneous pt 
population when 
M V 72hours is 
required. One 
study done by 
Young et al 
com pared HVLP 
to LVLP ETT
N ot well
documented but the 
article does say that 
VAP prevention 
may best be 
achieved with a 
multifaceted 
multidisciplinary 
bundle o f  simple 
interventions such 
as hand hygiene, 
position HOB 
elevated, oral 
hygiene, Studies o f 
these newer devices 
has been under 
powered for risk vs 
benefit, cost 
effectiveness 
mortality, safety, 
and potential injury.
Same as above; 
current evidence is 
still inconclusive on 
the effects o f the 
specialized ETT 
H M E, cost and 
prevention when it 
comes to VAP.
STR: The data 
provided was from 
w ell docum ented 
and recognized 
resources such as 
Lorente, and Kollef. 
This article set the 
tone for further 
investigation into 
novel prevention 
strategies to reduce 
VAP incidence. 
LIM : None listed 
but the article itself 
was not clear and 
lacked holding 
interest. It was not 
w ell laid out or 
labeled. H ard to 
read and follow.
None
reported
I don’t really 
have much 
comment. It 
was a 
redundant 
literature 
review that 
offered no 
new
prevention 
strategies for 
VAP. Yes it 
does support 
the capstone 
on the sense 
that more 
research is 
needed on the 
subject o f 
VAP
prevention
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stated these 
ETTs reduced 
aspiration. A 
R C T by Lorente 
et al revealed in 
polyurethane 
cu ff ETT w ith no 
SSD VAP were 
31 or 22% o f  140 
pts com pared to 
ETT w ith SSD 
11 or 8% o f  the 
140 pt 
population.
Silver coated 
ETT Keller et al 
report in a 
multicentre RCT 
there was a 
35.9% VAP 
reduction in a 
2003 pt
population M V 
greater or equal 
to 24 hours from 
54 o f  the centers, 
and a 4.8 vs.
7.5% lower VAP 
incidence among 
pts incubated for 
greater than 24 
hours. IN  a m eta­
analysis H ess et 
al found a lower 
risk o f  VAP with 
heat-and 
moisture- 
exchange (HM E) 
than with heat 
mummification. 
There was 
disputed 
controversy and 
added risk with 
all o f  these ETT 
and HM E 
methods.
Current evidence is 
still inconclusive.
and that most 
o f  the article 
reviewed thus 
far concludes 
that
prevention 
w ill probably 
be achieved 
m ore my 
m ultifaceted 
and
m ultidisciplin 
ary measures.
Is there a Johnso M ultidisci Retrosp Level - To determine Group 1-Pts Retrospective From  2003 to 2007 Because this was an STR: The use o f None I really liked
benefit to n, V., plinary ective III the im pact o f with VAP- data collection there w ere 805 pt open trauma ICU retrospective data reported this article. It
m ultidiscipli M angr rounds chart the institution o f 83 total from  chart requiring M V and a the need for M DR proved valuable in was easy to
nary rounds am, (M DRs); review M DRs in a from  2003 review o f  trauma total o f  4508 vent was supported with supporting the need follow, well
in an  open A., VAP trauma ICU to 2005 ICU  pts who days. Significant the inform ation this for M DR and the laid out to see
trauma M itche regarding VAP. before required difference was seen retrospective data reduction o f  VAPs the results and
intensive ll, C., implementa mechanical before M DR and provided. W ith the in open traum a read the
care unit Lorenz tion o f ventilation (MV) after M DR. Group need to eliminate ICU. LIM: Only m ethods used.
regarding o, M., M DR mean from  2003 to 1-Pts w ith VAP-83 VAPs and the done at one facility It also
ventilator- Howar age 40.5, 2007 no longer total in 2414 vent im pact this disorder and only one open supports the
associated d, D., and Group- than 48 hours. days show a ratio o f w ill have on future trauma ICU. I do fact that VAP
pneumonia? & 2 Pts with U sing the 34.3 VAPSs /1000 reim bursem ent the feel the results prevention is
The Dunn, VAP-49 International vent days from  2003 im plem entation o f w ould be close to a multi-facet
American E., from  2005 Classification o f to 2005 before M DR in the support the same in other approach and
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Surgeon, (2009) to 2007 D iseases 9th im plem entation o f to  decrease VAP is types o f  ICUs with props up the
75(12), after M DR Revision codes M DR and G roup-2 evident. MDR. need to look
1171-1174. implementa 
tion mean 
age 43.3.
and using the 
center o f  D isease 
Control and 
Prevention 
(CDC) criteria 
for VAP.
Pts with VAP-49 in 
2094 vent days 
show a ratio o f  23.4 
V APs/1000 vent 
days from  2005 to 
2007 after M DR 
implementation. (p 
= 0.04)
further at
VAP
prevention
strategies
those
currently
practiced and
novel ones as
well.
Current Kjone From  the Descrip Level-V V alidate the 41 A descriptive There was RNs and RTs STR: Over 2/3 o f None The fact that
practice in gaard, Journal tive need for Registered comparative significant differed the survey reported there is a
airway R., Airway compar com pliance to Nurses design was used difference existed significantly in the distributed were difference in
management Fields, M anagem e ative EB P’s to reduce (RN) and on 41 RN s and between R N  and RT m anagem ent o f  pts returned. Lim:The the care
: a W ., & nt Practice design VAP incidence 25 25 RT who for hyper on the vent. The survey was done at provided to
descriptive King, Respiratory m anaged ICU pt oxygenation before standard o f  care one location vented pts by
evaluation, M ., L., Therapist on MV. suctioning. RT should be consistent RNs and RTs
A merican (2012) (RT) D escriptive and instilled saline and using EBP could impact
journal o f inferential rinsed the closed interventions. the pt
critical care statistics were system with NSS outcome and
, 19(2), 168- used to analyze more than RN. RN be a factor in
172. the data 
collected.
gave oral care more 
than RT.
the
development 
o f  a VAP.
This article 
strongly 
supports that 
consistent 
com pliancy to 
VAP
prevention 
strategies by 
all healthcare 
members 
directly 
caring for the 
M V p t could 
reduce VAP 
incidence.
Silver- Kollef, PUBMED: Prospec Level-I To determine if A  total o f Pts were VAP were 4.8% P t receiving Str: Very well Research The study was
coated M., Silver tive VAP incidence 9417 adult assigned to with pts intubated intubation w ith the designed RCT and grant conducted
endotracheal Beckel coated RCT could be pts were undergo with the sliver- silver-coated ETT w ell supported by from  C. w ell but there
tubes and e, A., ETT and reduced using screened intubation w ith 1 coated ETT and had a reduction in statistical data. R. B ard are factors
incidence o f Anzuet VAP the sliver-coated between o f  2 HVLP ETTs 7.5% with the the VAP incidence. Safety for both Inc. that could
ventilator- o, A., incidence ETT thus 2002 and sim ilar except uncoated ETT groups was never have
associated verem reduces 2006. A one was silver- an issue. Lim: influenced to
pneumonia, akis, mortality rates. total o f coated. Other factors like outcomes.
JAM A,300( C., 2003 pt secondary problems Some pt
7), 805-813. Kerr,
K.,
M argo 
lis, B., 
Craven 
, D., 
Robert 
s, P., 
Arroli 
ga, A., 
Hubm  
ayr,
expected to 
be M V for 
24 hours or 
longer were 
randomized
the pts may have 
been experiencing 
that contributed to 
their M V situation. 
And, the time o f 
when the
respiratory culture 
was obtained varied 
with pts.
developed 
their VAP 
before the 48 
hour period 
and thus may 
have had 
contributing 
risk factors 
that made 
them  a VAP 
regardless o f 
w hat tube was
NR706C_PageJo_wk8CAPSTONE PROJECT 48
R.,
Restre 
po, M., 
Auger, 
W ., & 
Schinn 
er, R., 
(2008)
use for 
intubation. I 
detected some 
bias in results. 
The article 
w ill support 
the Capstone 
in the sense 
that it
supports the 
need to look 
closer at the 
design o f  the 
ETTs as a 
method to 
reduce VAP 
incidence.
The
ventilator 
care bundle 
and its 
impact on 
ventilator- 
associated 
pneumonia: 
a review o f 
the
evidence. 
Nursing in 
Critical Car, 
16(5), 222­
233.
Lawre 
nce, P. 
Fulbro 
ok, P., 
(2011)
PUBMED:
M icroaspir
ation,
VAP,
N osocomi
al lung
infection,
ventilator
care
bundle
Literatu
re
Review 
from  10 
researc 
h
studies
Level - I To critically 
analyze recent 
research that 
has investigated 
ventilator care 
bundle (VCB) 
use and the 
im pact on VAP 
outcomes.
From  all the 
meta­
analysis 
listed the 
studies 
were
conducted 
on adult 
ICU MV 
pts at 
multiple 
times and in 
multiple 
facilities.
Retrospective 
data analyzed 
from  the 10 
research articles.
Some studies 
indicated that the 
w hen the VCB was 
used consistently the 
VAP incidences 
were reduced. But, 
due to identified 
limitations more 
thorough evaluation 
o f data collected on 
each VCB indicator 
must be more tightly 
im plem ented in 
order to carefully 
evaluate the 
effectiveness o f  the 
VCB strategies.
This paper strongly 
supports that there is 
a lack o f 
standardized care 
for M V pts with or 
w ithout the VCB 
implementation.
STR: The article 
supports that MV 
pts are not 
consistently 
receiving 
standardized EBP 
interventions. LIM: 
Data was not 
clearly illustrated in 
this article Tools 
that some o f  the 
studies used for 
their data collection 
were not provided.
None
reported
Perhaps a 
reduction in
VAP
incidence can 
be associated 
with
com pliancy to 
VCB but the 
data and 
method upon 
which Quality 
Improvement 
(QI) is 
collected 
m ust be kept 
consistent. 
EBP
intervention 
should be the 
standard for 
all M V pts 
regardless 
what
institution the 
intubation 
occurs. This 
article may 
not
necessarily 
support the 
Capstone but 
it does 
support the 
fact that 
prevention o f 
a VAP starts 
the mom ent 
that pt is 
intubated 
regardless o f 
w hat ETT is 
used.
Prevention
o f
Leasur
e,A.,
D atabase
Cochrane:
Histori
cal
Level-I 
and II
Examine the 
effectiveness o f
H um an
subject
Assessm ent o f 
data extrapolated
The presence or 
absence o f  a VAP;
The goal o f  the 
study was to
STR: The 
systematic review
None
reported
The
systematic
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ventilator- 
associated 
pneumonia 
through 
aspiration of 
subglottis 
secretions. a 
systematic 
review and 
m eta­
analysis. 
D imensions 
o f Critical 
Care 
Nursing, 
31(2), 102­
117.
Stirlen
, J.,
Shu
Hua
Ku,.
(2012)
Prevention 
, VAP, 
subglottis 
secretions,
D esign
using
system
atic
review
and
meta-
analysi
s based
on
studies
that
focused
on
subglot
tis
secretio
n
drainag 
e, used 
prospec 
tive 
design, 
sample 
d only 
humans 
, and 
had a 
control 
group
subglottis 
secretion 
aspiration in 
reducing VAP 
thus reduce 
VAP rates, and 
tim e being MV, 
mortality, and 
LOS
hospitalized 
in an  ICU 
who were 
intubated 
and MV.
from  the selected 
studies, and two 
reviewer 
independently 
assess the studies 
for appropriate 
methodology, 
quality, and then 
used a
standardized 
checklist to 
appraise and 
summarize the 
results. If there 
w ere
disagreements 
they were 
resolved through 
further
discussion o f  the 
two reviewers 
and a third party.
M ortality rate; VAP 
incidence/1000 vent 
days; D ays to onset 
o f a VAP; Duration 
o f M V; LOS
examine the 
effectiveness o f 
SSD aspiration on 
V AP reduction, The 
findings o f  the 
systematic review 
dem onstrated a 50% 
reduction in VAP 
rates when an  ETT 
had SSD compared 
to a ETT without 
SSD. A  two day 
shorter duration o f 
M V was also seen in 
m ost experiment 
groups than in most 
control groups 
across studies.
was w ell selected 
by highly 
recognized RCT. 
The use o f  the 
tables made the 
article easy to 
follow. LIM : I see 
some potential for 
bias as no articles 
were selected to 
show the negative 
side o f  SSD 
aspiration.
review was 
w ell done and 
presented in a 
clear and 
logical order 
in the article. 
These authors 
really took 
some tim e to 
prepare the 
data and made 
a deliberate 
effort to 
rem ain none 
bias to the 
results. 
However, 
there are 
article and 
studies that 
dispute the 
SSD
aspiration
method.
There are also 
strong 
indications 
that even 
better
designed ETT 
and cuffs may 
also reduce
VAP
incidence and 
cause less risk 
o f  harm  to the 
pt. The use o f 
tables in the 
article made it 
easy to see 
the results o f 
the data. I 
really enjoyed 
this article. 
W ell done. 
This supports 
a Capstone 
objective o f 
bringing 
about
standardized 
care to the 
M V ICU 
adult
population.
Change 
Theory by 
K urt Lewin. 
Retrieved 
October 8, 
2011, from
0 Retrieved 
October 8, 
2011, from 
http://curre 
ntnursing.c 
om/nursin
No
researc
h
design 
but this 
theory
NA NA NA NA NA NA NA NA The Kurt 
Lewin 
Change 
Theory has 
been widely 
used in
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http://curren
tnursing.co
m/nursing_t
heory/chang
e_theory.ht
ml
g_theory/c
hange_the
ory.html
o f
change 
w ill be 
used in 
the
implem 
entatio 
n  o f 
change 
s to
practice 
based 
on the 
results 
and
outcom
es
identifi 
ed in 
the
Capsto
ne
Project.
changing 
practices in 
the nursing 
profession. It 
is clear, 
concise, and 
easy to 
understand at 
m ost levels o f 
healthcare 
workers. 
Unfreeze, 
m ove to the 
new level o f 
change and 
Refreeze. The 
plan is to 
implement 
this model if 
change in 
practice is 
warranted.
New issues 
and
controversie 
s in the 
prevention 
of
ventilator- 
associated 
pneumonia. 
A m  J Respir 
C rit Care 
Med. 182, 
870-876.
Lorent 
e, L., 
Blot, 
S., & 
Rello, 
J., 
(2010)
PUBMED:
Issues;
controversi
es;
prevention
;VAP;
cuff;
coated
tube;
tracheotom
y;
humidifier
Syste m 
atic 
review 
o f  RCT 
or
meta-
analysi
s
Level-I To review 
current VAP 
prevention 
strategies that 
w ere not clearly 
recom mended 
in the past. and 
make strong 
argum ent for 
their application 
in today’s 
practice to 
prevent VAP.
So me 
studies 
stated adult
M V
population 
in ICU ’s 
some did 
not clearly 
specify the 
population.
H istorical 
retrospective 
design data 
critiqued from 
highly respected 
studies using the 
criteria; if  the 
recom mendation 
s were supported 
by a R CT or 
meta-analysis, 
and there were 
no reservations 
about the 
benefits, harm, or 
cost. If  the 
recom mendation 
s by R C T or 
m eta-analysis it 
was defined as 
more research 
needed.
Based on the 
credible studies that 
m et the criteria o f 
the authors a brief 
summary: ETT with 
SSD-recommended; 
ETT with ultra thin 
cuff and SSD-worth 
consideration; one 
study was done by 
Lorente in 2006. 
ETT with ultra thin 
cuff no SSD- worth 
consideration. 
Constant pressure 
inflation cuff-more 
research needed. 
ETT w ith SSD and 
LVLP constant 
pressure inflation 
cuff--more research 
needed. D evice to 
rem ove biofilm- 
more research 
needed. Saline 
instillation before 
suction-more 
research needed. 
Early tracheostomy- 
worth
recommendation. 
ETT silver coated- 
recommended. Heat 
m oisture exchange 
(HM E)-worth 
consideration
Obviously more 
research is needed 
and should be on­
going on the best 
approach to VAP 
prevention. A ll must 
consider benefits, 
harm  and cost
STR: definitely 
looked at the best 
studies that have 
been done on MV 
pts. It was fair and 
balanced. Very 
clear, concise in the 
recom mendations 
and rationale for 
their
recommendations. 
W here there was 
some concern on 
sample size or data 
results the authors 
did define that more 
research is needed. 
LIM : Lack 
inform ation on cost 
effectiveness, 
mortality, duration 
o f  M V, LOS, and 
specific population.
Stijn 
B lot did 
receive 
$1001-
$5000
for
Covidien 
and 
$1001- 
$5000 
form 
Cook 
Critical 
Care in 
lecture 
fees.
Covidien does
manufacture
the
M allinckrodt 
HVLP and 
Seal Guard 
ETTs endorse 
by Lorente 
and lecture 
fees were 
provided to 
Blot this 
could lead to 
a somewhat 
bias in their 
opinions and 
recom mendati 
ons. One o f 
the studies in 
the systematic 
review was 
conducted by 
Lorente. The 
systematic 
review was 
well
completed 
and the 
criteria for the 
article chosen 
were very 
precise. This 
review 
definitely 
supports the 
Capstone 
Project in the 
fact that when
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m ulti-facet 
prevention 
strategies are 
implemented 
VAP rate can 
be reduced. 
M ore research 
is needed to 
continue the 
surge tow ard 
better VAP 
prevention 
healthcare 
practices. 
M ore
consideration 
on ETT 
selection must 
continue and 
further studies 
on the effects 
m ust be done.
A
polyurethan 
e cuffed 
endotracheal 
tube is 
associated 
with
decreased 
rates o f 
ventilator- 
associated 
pneumonia. 
Journal 
Critical 
Care, 26(3). 
280-286.
Miller,
M.,
Arndt,
J.,
Konkl
e, M., 
Cheno 
weth,
C.,
Iwashy 
na, T., 
Flahert
y, k ., 
&
Hyzy,
R.,
(2010)
CINAHL
and
PUBMED:
VAP;
nosocomia
l
infections; 
M V; ETT
Observ
ational
researc
h
design
Level-
III
controll 
ed trial 
no
randomi
zation
To determine 
whether the use 
o f  polyurethane- 
cuffed ETT use 
results in VAP 
incidence 
reduction.
A ll adults
M V
throughout 
a large 
academic 
hospital 
from  2007 
to 2008.
Product 
replacem ent o f 
the ETT from  a 
conventional 
ETT to the 
polyurethane- 
cuff
(KCHVLPM C) 
and retrospective 
appraisal o f  VAP 
rates before 
im plementation 
and after 
im plementation 
o f  the new ETT 
and com pleting a 
time-series 
analysis.
VAP rates decreased 
for 5.3% /1000vent 
days before the use 
o f  new ETT to 2.8% 
/1000vent days
Use o f the new 
polyurethane -  
cuffed tube was 
associated with a 
decreased rate o f 
VAP incidence.
STR: The 
observation data 
was real-time. The 
observers w ere able 
to collect data at the 
tim e and eliminate 
some extraneous 
variables. The 
multi-facet 
healthcare team  can 
be observed real in 
real life settings. A 
generalization 
based on
observation can be 
m ore situational 
this can account for 
the com plexity o f 
m ulti-group 
behaviors such as 
com pliance to Vent 
bundle protocols. 
LIM : Observation 
o f  real practice over 
many shifts is time 
constraining. Bias 
am ong observers 
can occur. Subject 
source many be 
unequal.
Study
partially
funded
by
Kimberle
y Clark
Corp.
(KCC)
which
manufact
ures the
KCHVL
PMC
ETT.Dr
Hyzy
received
&5800.0
0
consultat 
ion fee 
for KCC 
and a 
$6000.00 
educatio 
nal grant.
The fact that 
this w ell done 
observation 
study was 
heavily 
funded by one 
o f  the authors 
lends itse lf to 
a strong bias. 
The
researcher 
may only see 
w hat they 
w ant to. See. 
Source o f 
subjects could 
be questioned. 
Any group 
that is studied 
especially via 
observational 
method can 
be skewed to 
some degree. 
The article 
did conclude 
that V A P still 
hold a high 
m ortality and 
healthcare 
cost. I f  a 
simple change 
in ETT use 
reduces VAP 
it is worth it. 
This article 
definitely 
supports the 
Capstone
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Project and I 
have no 
conflict o f 
interest or 
strong bias 
with any ETT 
manufacturer. 
Strong choice 
o f  references 
like
Dullenkopf, 
Lorente, 
Kollef, and 
Rello; these 
are experts on 
the issue o f 
VAP
prevention.
Subglottic 
drainage o f 
secretions 
reduces 
VAP (m eta­
analysis; 
review). 
Critical Care 
M ed, 39(8), 
1985-1991.
M usce
dere,
J.,
Rewa,
O.,
M cKe
chnie,
K.,
Jiang,
X.,
Laport 
a, D.,
&
Heylan 
d, D., 
(2011)
PUBMED: 
Subglottic 
secretion 
drainage 
(SSD); 
prevention 
; VAP; 
m eta­
analysis
Searche
d
comput
erized
databas
es,
referen 
ce lists 
and
persona
l files
R CT o f
M echa
nical
ventilat
ed
(M V)
pts
compar
ing
standar
d ETTs
to SSD
ETTs
Studies
w ere all
meta-
analyze
d for
primary
outcom
es o f
VAP
and
second
ary
clinical
outcom
es.
Level-I Aspiration o f 
secretions 
containing 
bacteria 
pathogens that 
causes VAP. 
ETTs w ith SSD 
as a prevention 
o f  VAP.
PCT
equaling
N=2442
Literature 
Review; Study 
identification:
A ll relevant 
articles using 
reputable 
databases. Study 
selection criteria: 
R C T o f  adult 
M V critically ill 
p t ; Data 
synthesis: 
Primary 
occurrence o f 
VAP. Secondary 
ICU and hospital 
Length o f  stay 
(LO S) mortality, 
antibiotics, safety 
data. Primary 
and secondary 
analysis: Only 
studies that met 
the inclusion 
criteria and 
subgroups o f 
high-quality 
studies using a 
m edian score.
13 random ized 
clinical trials that 
m et the inclusion 
criteria w ith a total 
o f 2442 randomized 
patients. O f the 13 
studies, 12 reported 
a reduction in VAP 
rates in the SSD 
arm; in m eta­
analysis, the overall 
risk ratio for VAP 
was 0.55 (95% 
confidence interval, 
0 .46-0.66; p < 
.00001) with no 
heterogeneity (I2 _ 
0%). The use o f 
SSD was associated 
w ith reduced ICU 
LOS ( 1.52 days; 
95% confidence 
interval, 2.94 to 
0.11; p = 03); 
decreased duration 
o f mechanically 
ventilated (1.08 
days; 95% 
confidence interval, 
2.04 to 0.12; p =
03), and increased 
time to first episode 
o f VAP (2.66 days; 
95% confidence 
interval,1.06 -  4.26; 
p = 001). There was 
no effect on adverse 
events or on hospital 
or ICU mortality
In those at risk for 
VAP, the use o f 
ETTs with SSD is 
effective for the 
prevention o f  VAP 
and may be 
associated with 
reduced duration o f 
M V and ICU LOS.
STR: W ell done 
and w ell supported 
by RCT. LIM: 
Some sources 
provided minimal 
data and the 
m ajority o f  studies 
used only one type 
o f  ETT com pared to 
the SSD ETT.
None
reported
The use o f  a 
systematic 
review and 
m eta-analysis 
again show 
that a
m ultifaceted 
approach 
including 
novel 
prevention 
strategies like 
ETT designs 
m ust be given 
strong
consideration.
New 
tracheal 
tubes to 
prevent
Nseir,
S.,
(2011)
M EDLINE 
: VAP; 
new ETT; 
evidence
None
noted
Level-
IV
Source o f 
evidence that 
supports the use 
o f  newer
None
provided
Retrospective 
literature review 
supporting 
evidence.
Silver coated ETT 
were found to 
reduce VAP but 
there is lim itation on
Further designed 
studies are needed 
before a ETT 
recommendations
STR: Strong and 
w ell stated opinion 
LIM : The opinion 
may not be shared
None
reported
I do share the 
opinion o f  the 
author and I 
agree that
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ventilator- designed ETTs the studies that can become the by those who have m ore research
associated vs the standard made a standard o f  practice put time and effort into the best
pneumonia: tube recom mendation in M V pts. into the studies that preventive
where is the M EDLINE: only. Same was true have been strategies to
evidence? VAP; new ETT; for polyurethane conducted. reduce VAP
Critical evidence cuffed tubes only a may lie in the
Care,15(6), recom mendation. It newer
459. is clear that more 
RCTs need to be 
conducted on newer 
designed ETTs.
designed 
ETTs. This 
opinion does 
support the 
need for my 
Capstone 
focus.
Preventing O ’Gra M EDLINE Case Level- Strong need for A adult Case study done Difficulty with In spite o f  VAP STR: Strong food None Excellent
ventilator- dy, N., study VII available studies ICU pt on one M V pt. diagnosing VAP prevention bundles for thought. I to reported article. It does
associated M urry, Preventing to include intubated that resulted in a VAP is still a have seen some support the
pneumonia P., ; VAP interventions and re- death. leading killer in cases where I did need for more
Does the Ames, that improve intubated ICU ’s. Before feel the pt had a research to be
evidence N., patient clinicians adopt the VAP but it was done on VAP
support the (2012) outcomes before VAP bundle for all other risk factors prevention
practice? they are M V p t’s evidence like an aspiration strategies and
JAMA, im plem ented as needs to be credible prior to intubation considering
301(23), prevention and strong based on that caused the m ore novel
2534-2538. approaches in 
clinical practice.
im proved pt 
outcomes.
pneumonia. LIM: 
This was one case 
study, I am  sure 
there are others out 
there to support the 
need for consistent 
im plem entation o f 
VAP prevention 
strategies like VAP 
bundles.
strategies 
currently not 
included in 
VAP bundles 
like newer 
ETT designs. 
This supports 
my Capstone 
focus.
Ventilator- O ’Kee Cochrane Syste m Level-I To provide a Critically ill A  study was Outcomes: M ethodologically STR: W ell None This was a
associated fe- or atic review of adult pts evaluated on Outcomes that are strong R C T are organized reported systematic
pneumonia M cCar CINHAL: Literatu literature on with VAP certain inclusion identified in the necessary to systematic review review (SR)
bundled thy, S., VAP; re VAP bundles, criteria: Original majority o f  studies determine the with the data done in
strategies: Santia methodolo Review practice, quantitative both clinical and effects o f  EBP. A coming from Canada. I do
an evidence- go, C., gy; was definitions. To research done in process; VAP rate, strong studies various agree that the
based Lau, nosocomia conduct discuss English, bundled frequency, number organizational databases. authors
practice, G., l infection; ed in know ledge o f practices were o f  ventilator days, conceptual Investigators used conclusion
Worldviews (2008) intubation. M EDLI practice and examined and ICU LOS, mortality fram ework to the interrater found that
on evidence- ; adult; NE, actual clinical clinical outcomes rates, compliance im plem ent the reliability The acute R CT do carry
based ventilator CINHA settings o f  the critically rates. Results: Two transform ation o f Physiology and the highest
nursing, bundles; L, promotion. To ill adult with studies used the know ledge to Chronic Health level o f
5(4), 193- EBP; Cochra identify need VAP were CDC definition for practice is essential Evaluation evidence for
204. restricted ne, and for further assessed. VAP; number o f and depends on (APACHE) scores practice, it is
to PsycIN research to VAP/num ber o f effective leadership w ere used to assess also important
quantitativ FO prevent VAP. ventilator days x to champion the severity o f  illness that the data
e studies 1,000 and reported a 
decrease o f  VAP 
0.0-2.7 per 1,000 
vent days. . One 
study reported a 
strong relationship 
between V AP rates 
and compliance; in 
21 ICUs that had a 
95% compliancy 
rate VAP decrease
cause. EBP 
interventions are 
decreasing VAP 
rates and m ust be 
continued and 
closely monitored.
and supported 
validity o f  some of 
the outcomes.
LIM : Inconclusive 
evidence was 
revealed,
methodologies were 
sometimes 
inadequate, 
reporting o f  data 
was casual in some
is as strong 
and correct as 
possible.
W hat the SR 
did reveal was 
that even 
among 
facilities and 
direct care 
providers 
there is
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from  6.6 to 2.7 per 
1,000 vent days. A 
general trend seen in 
most studies was 
that the number o f 
vent days decreased 
from  6.1 to 3.5 days. 
The LOS in ICU ws 
variable as some did 
not report this data. 
M ortality rates also 
were not addressed 
in the m ajority o f 
studies. The 
compliance rate to 
VAP prevention 
bundles was 
increased in m ost of 
the studies up 20 % .
studies, inconsistent 
protocols were 
seen, study results 
were careless a in 
some studies. 
Internal and 
external validity 
compromised.
inconsistency 
in the practice 
and
interventions 
that M V p t’s 
receive. It 
does support 
the Capstone 
in the sense 
that more 
research is 
needed to 
investigate 
effective 
strategies that 
are
standardized 
and do 
support the 
reduction in 
VAP 
incidence.
Analysis o f 
overall level 
o f evidence 
behind the 
institute o f 
healthcare 
im provemen 
t  ventilator- 
associated 
pneumonia 
guidelines. 
Southwest 
Journal o f 
Pulmonary 
and Critical 
Care, 3: 40­
48.
Padrno 
s, L., 
Bul,
T.,
Pattee,
J.,
W hitm  
ore, E., 
Iqbal
M .,
Lee,
S.,
Singar 
ajah, 
C., & 
Robbi 
ns, R., 
(2011)
PUBMED:
VAP;
VAP
bundle
Syste m 
atic 
review 
of
literatur
e;
studies 
were 
require 
d to be 
prospec 
tive and 
controll 
ed in 
design.
Level o f 
evidenc 
e I
through
IV
variable
Assessm ent of 
the quality o f 
evidence 
underlying 
recommendatio 
ns from  one 
medical 
regulatory 
organization the 
Institute o f 
H ealthcare 
Improvement 
(IHI) regarding 
guidelines for 
VAP prevention 
and or VAP 
bundles.
Each study 
had a 
different 
population 
size (see 
results) but 
combined 
total o f 
5097 pt 
audits 
representin 
g 5800 vent 
days, and 
each author 
examined 
their own 
ICUs where 
they
w orked for 
evidence o f 
a
correlation 
between 
guidelines 
compliance 
and the 
developmen 
t o f VAP. 
IRB
approval
Retrospective 
data collection 
from  individual 
studies that met 
the criteria for 
selection. Studies 
w ere required to 
be prospective 
and controlled in 
design. Only 
studies
demonstrating a 
reduction in VAP 
w ere considered. 
The A merican 
Thoracic Society 
grading system 
was used to 
assess the 
underlying 
quality o f 
evidence for the 
IHI VAP 
guidelines and 
includes levels 1 
high, 11 mod, 11 
low, and 1V no 
evidence o f 
improvement.
Elevation head o f 
bed-31 articles-8 
used, level 11- mod 
recommendations; 
Daily sedation 
vacation- 66 
articles-4 used-level 
111- w eak 
recommendation; 
Daily readiness to 
w ean or extubate-47 
articles-3 used-level 
111-weak 
recommendation; 
Daily spontaneous 
breathing trial-29 
articles-1 used- 
level-111- w eak 
recommendation; 
Peptic ulcer 
diasease-52 articles- 
9 used-level 1V- 
weak
recommendations;
D eep venous
thrombosis
prophylalxis-14
articles-2 used-
level-111-weak
recommendation.
As seen above they 
were unable to show 
that im proved VAP 
guideline 
compliance 
correlated w ith a 
reduced incidence o f 
VAP. Agencies like 
the IHI should show 
restrain in guideline 
form ation based on 
the opinion or 
e=weak conflicting 
evidence. Only 
those with strong 
backing evidence 
should be 
designated as a 
guideline.
STR: D rakulovic et 
al. conducted a 
R CT 86 M V pts on 
HOB. K ress et al. 
conducted a RCT 
on 128 adult pts 
M V for sedation 
vacation. The other 
outcomes did not 
indicate the study 
used. A  large 
population was 
used for this 
systematic review. 
LIM : All data came 
from  the Phoenix 
VA hospitals. No 
data on negative 
consequences if  the 
IHI guidelines were 
not mandated and 
monitored.
None
reported.
W OW  this 
has given me 
food for 
thought. This 
could be bias 
opinion; as 
w ell as 
selection in 
the studies 
used. I do 
agree that 
m ore studies 
are needed 
and there has 
to be more 
investigation 
into novel 
prevention 
strategies like 
the ETT 
designs and to 
aid in
determining 
the best 
standardized 
practice that 
M V pts 
should
receive. M ore 
work need to 
be done 
especially 
w hen hospital 
reim bursem en 
t  is based on 
prevention. 
The question 
is can VAP 
ever be
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eliminated. I 
say no, but it 
can be 
reduced.
A
randomized 
trial o f 
dental
brushing for 
preventing 
ventilator- 
associated 
pneumonia. 
Chest, 
136(2), 433­
439.
Pobo,
A.,
Lisboa 
, T., 
Rodriq 
ues,
A.,
Sole,
A.,
M agret
, M.,
Trefler
, S.,
Gomez
, F., &
Rello,
J.,
(2009)
PUBMED: 
Download 
ed from 
chestjourn 
al.chest.pu 
bs by guest 
on M ay 
15, 2012 
www.chest 
journal.org
Single­
blind
prospec
tive
study
o f
standar 
d oral 
care 
with 
0.12% 
Chlorh 
exidine 
digluco 
nate 
(standa 
rd
group)
vs
standar
d oral
care
plus
electric
tooth
brushin
g
(toothb
rush
group).
Level
o f
Eviden
ce
Level-
II
Potential 
relationship o f 
oral care to 
VAP incidence. 
The hypothesis 
was that 
im proved oral 
care with the 
electric tooth 
brushing may 
help reduce 
VAP incidence.
A  large
med/surg
ICU at an
urban
teaching
hospital.
IRB
approval.
A ll adult 
pts who 
were 
intubated 
w ithout 
incidence o f 
pulmonary 
infection 
and trialed 
w ithin 12 
hours o f 
intubation if 
expected to 
be intuabed 
for longer 
than 48 
hours. 147 
pts were 
randomized 
74 w ere in 
the
toothbrush
group.
A  prospective 
single-blined 
R C T o f  adult pts 
intubated for > 
than 48 hrs. 
Controlling for 
exposure to 
antibiotic 
treatment, pts 
were randomized 
to oral care every 
8 hrs w ith 0.12% 
Chlorhexidine 
digluconate 
(standard group) 
vs standard oral 
care plus electric 
tooth brushing 
(toothbrush 
group). VAP was 
docum ented by 
quantitative resp 
cultures. M V 
duration, LOS, 
antibiotic use, 
and m ortality 
were all 
secondary 
outcomes
The groups were 
comparable at 
baseline. VAP 
(20.3% vs 24.7% p= 
0.55).
Oral care with the 
electric toothbrush 
using 0.12% Chlor 
dig is not effective 
for the prevention o f 
VAP.
STR: First study to 
evaluate a different 
oral care protocol. 
Intervention simple 
and safe. LIM: 
Possible type II 
errors, possible lack 
o f  compliance by 
healthcare staff. A 
single study. Lack 
o f  standard oral 
care
recommendations.
None
reported
Very
interesting 
R CT that may 
put to rest the 
use o f  electric 
toothbrush 
oral care. 
Evidence 
does show 
that certain 
oral care 
guidelines 
may reduce 
VAP risk. I 
am  convinced 
that novel and 
know n 
preventive 
strategies 
such as oral 
care
guidelines 
w ill be a 
factor in VAP 
preventions 
strategies in 
the future.
Using
evidence-
based
practice to
prevent
ventilator-
associated
pneumonia.
Critical Care
Nurse,
32(4), 41­
50.
Sedwi 
ck, M. 
Lance- 
Smith,
M.,
Reeder
, S., 
Nardi, 
J., 
(2012)
Retrieved 
from  the 
actual 
journal: 
EBP;
VAP;
prevention
Review
o f
literatur
e;
studies
with
RCTs,
retrosp
ective
chart
reviews
o f  data
from
previou
s trials
and
meta-
analysi
s.
Levels - 
I, II, III
To develop a 
V ent bundle and 
care practices 
for critical care 
nurses to reduce 
the rate o f  VAP.
ICUs in 
Lankenau 
Hosp. Pa. 
on 105 staff 
nurses, a 
total o f 
4709 Vent 
days were 
audited 
from  Jan 
2009 
through 
Dec. 2009.
The IHI protocol 
for oral care, 
hand washing, 
HOB, SSD; 
compliance audit 
calculated by 
electronic 
feedback was 
conducted.
A dherence to vent 
bundles increased. 
Compliance for 
peptic ulcer dx 
prophylaxis, DVT, 
sedation vacation, 
and elevated HOB 
w ere greater than 
98%. Compliance 
rate for oral care 
increased from  76% 
to 96.8%. Readiness 
for extubation 
reached 92.4%.
VAP decreased 
from9.47 to 1.9/100 
vent days. Saving 
from  VAP rate 
decrease was 
approx. $1.5 
million.
Strict adherence to 
bundle practices for 
V AP prevention, 
interdisciplinary 
collaboration 
im proved patients’ 
outcomes and 
produced a marked 
savings in cost.
STR: Compliance 
data was collected 
by QI staff.
SM ART approach 
described by K ollef 
an expert in VAP 
prevention was 
used. Education 
support was a big 
part o f
implementation. 
Computer data 
completed the 
calculations. VAP 
reduction was 
achieved. LIM: 
Short tim e frame 
but I really don’t 
see too many 
limitations.
None
reported
W ell done 
nurses. I think 
I could adopt 
many o f  the 
strengths 
from  this 
article’s 
example for 
future use. 
Excellent 
studies were 
selected that 
are
consistently 
referenced by 
others for a 
resource and 
literature 
reviews. This 
can support 
my Capstone
by
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strengthening 
the argum ent 
for more 
com pliance to 
vent bundles 
and
maximizing 
the ebp 
strategies we 
already have.
Endotrachea 
l tube cuff 
design and 
function. 
Anesthesiol 
ogy news 
guide to 
airway 
management
ANESTHES
IOLOGYN
EW S.COM.
51-56.
Spiege 
l, J.,
(2010)
PUBMED:
New
designed
ETT
compariso
n
Literatu
re
review
Level-
VII
Overview o f 
newer ETT 
designs
Adults and 
pediatric 
population 
is given is 
mentioned
N one disclosed None included Some major recent 
im provements in 
ETT cu ff design 
have offered 
clinicians real 
choice in device 
usage. C uff designs 
are adding to safety 
and VAP 
reductions.
LIM :No real data 
and statistics to 
back up opinion.
None
reported
A great article 
and many 
studies do 
support that
VAP
reduction can 
occur with the 
use o f  these 
newer
designed ETT 
even if  it is a 
small 
reduction.
This is a w eak 
level o f 
evidence 
source but 
done better 
the author 
could have 
added greatly 
to the need to 
investigate 
new er ETT 
designed 
further in the 
future to 
support the 
evidence for 
practice.
Pneumonia 
in the 
surgical 
intensive 
care unit: Is 
every one 
preventable? 
Surgery,
150: 665­
672.
Wahl,
W.,
Zalews
ki, C.,
Hemm
ila, M .,
&
Arbor,
A.,
(2011
).
PUBMED:
Surgical
ICU;
pneumonia
prevention
Retrosp 
ective 
review 
o f  all 
M V pts 
in
mixed
surgical
ICUs
who
develop
ed
pneum
onia
from
2006 to 
2008.
Level-
III
To prove that 
many acutely 
injured pts 
develop 
pneumonia at 
the tim e o f 
injury in spite o f 
m easures to 
prevent it.
There were
208 M V pts 
who
underwent 
bronchoalv 
eolar lavage 
(BAL) 
specimens 
ha lf o f 
which were 
performed 
the first 48 
hours of 
admission. 
IRB
approved.
Retrospective 
review o f  these 
M V pts from 
m ixed ICUs who 
developed 
pneum onia from 
2006 to 2008 and 
w ere vented > 
than 48 hours.
O f the 208 M V pts 
who underwent 
bronchoalveolar 
lavage (BAL) 
specimens h a lf  o f 
which were 
performed the first 
48 hours o f 
admission. 58%  had 
a positive BAL 
culture but no VAP. 
Only 10% o f  pts 
studied with early 
BAL had no growth. 
25 pts with a 
positive BAL on 
early BAL 
underwent repeated 
BAL and 16 (64%) 
were later diagnosed 
with VAP.
M any intubated pts 
in the surgical ICus 
had evidence o f 
early pneumonia or 
bac, growth w ithin 
48 hours o f  arrival 
to  the ICUs. 
Indicating pt -  
derived rather than 
environmental 
acquired source may 
add to VAP risks.
STR: The findings 
seem  to indicate 
that factors o f 
developing VAP 
can be multiple. 
LIM: No real 
deviation o f 
m edical and 
surgical pts. It was 
a small single­
centered study.data 
that was 
retrospective.
None
reported
I feel the 
article did 
lend some 
m erit to the 
possibility 
that the 
bacteria 
sources that 
can cause a 
VAP is not 
easily
contained or 
isolated. This 
adds to the 
vulnerability 
o f  pneumonia 
such as a 
VAP if  M V in 
the already 
com promised 
injured pt.
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Brushing Yoa, Cochrane: RCT Level-II Study the N=53 male M V support for N=53 after 7 days of Protocol using STR: D esign was Grants Results could
teeth with L., Ventilator- pilot effects in a 64.2% at least 48 hrs, tooth brusining toothbrush with rigorous RCT. by be seen as
purified Chang, associated neurosurgical mean age and no current method, VAP rate purified water can LIM: Sample small. Taiwan bias based on
water to C., pneumonia ICU brushing 60.6. pneumonia. Both were lower exp gr reduce VAP and One center. National the grants.
reduce Maa, ; oral care; teeth tw ice daily groups received 17% than in con gr improve oral health Science The small
ventilator- S., tooth with purified the same oral 71% p<.05. and hygiene. Council study was
associated Wang, brushing; water on M V care. The exp gr and interesting
pneumonia. C., oral pts to  see if received tooth National and should be
Journal o f Chen, health; VAP rate were brushing with Health studied
Nursing C., oral reduced. purified water. Research further. It
Research, (2011) hygiene The con gr Institutio could become
19(4), 289- received regular n. a preventive
296. oral care 
moisturizing o f 
lips.
strategy for 
VAP if  more 
research is 
conducted. At 
this tim e I see 
it as a
consideration 
o f  novel 
strategies to 
prevent VAP.
The Zolfag PUBMED: Viewpo Level- To explore the None listed None listed None listed The paradigm  o f STR: I do agree PSZ has I do question
tracheal hari, Trach tube int VII published data VAP prevention w ith the opinion o f no a possible
tube: P., & article on support for strongly favors the authors LIM: competin strong bias
gateway to W ynco new er ETT and multi-faceted No strong evidence g and influence
ventilator- ll, D., their potential strategies aimed at for their opinion interests. from  one o f
associated (2011) contribution to reducing aspiration was found in the In the the authors.
pneumonia. VAP prevention o f  oropharyngeal article past 3 The article is
Critical strategies. secretions. W ith the years, not w ell done.
Care, 15(5), increasing w eight o f D W  has It is clear and
310- evidence pointing at 
the role o f  the 
tracheal tube design 
and maintenance o f 
adequate cuff 
pressures, is it really 
good medical 
practice to continue 
to use standard 
cuffed tubes?
acted as 
a paid 
consultan 
t  or given 
lectures 
on VAP 
for
Covidien
Kimberly
-Clark
and
Bard.
concise and I 
do agree that 
m ore research 
be done on 
the newer 
designed ETT 
and the part 
they can play 
in VAP 
reduction.
This is a main 
thread o f  my 
PICO and 
Capstone.
Can using a 
newer
designed ETT 
reduce VAP 
and provide 
better pt care 
outcomes? I 
hope to find 
some
evidence o f 
such a 
possibility.
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Appendix B
Conceptual Model for Prevention of VAP (Kane, 2011) 
And 
Logic Model for DNP Project (Zaccagnini & White) 2011)
Practice Issue of Concern:
• Ventilator associated pneumonia (VAP) a major source of hospital acquired infections in Intensive Care Units 
(ICU's)
• Higher morbidity and mortality and an overwhelming health care cost factor in the intubated adult patient 
population.
• Evidence shows that a VAP starts with a host factor and pathogen. Knowing this, several different
• Prevention strategies must be initiated at the time of the intubation that reduce the host factor and colonization 
of pathogens that contribute to a VAP. Craven (2006)
Clinical factors
• Hospital Acquired Infections 
(HAI) are common 
complications in an ICU 
especially in the adult intubated 
patient.
• Age of pt
• Diagnosis of pt prior to 
intubation
• Past hx of pt/risk factors
• Sputum and blood cultures prior 
to intubation
• Staff compliance to infection 
control standards and VAP 
bundle
Outcomes
• Assess vented pt population for VAP using CDC criteria
• Assess compliancy of the VAP bundle
• Assess decrease incidences of VAP cases
• Identify improved pt care outcomes in the adult ICU
intubated pt
Promote a Zero VAP incidence environment
Prevention Strategies
Implement ventilator bundle that are evidence base
practice driven
• Improve hand hygiene compliancy
• Prevent gastric and oral pharyngeal aspiration
• Elevate HOB
• Daily assessment for weaning and sedation
vacation
• Oral care protocol to prevent oral tracheal
secretion contamination
• Endotracheal tube cuff management.
• Blood Sugar control
• DVT prophylaxis
• Peptic ulcer prophylaxis
• Consider implementing endotubes designed to
be high volume lo pressure micro cuffed
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r
Project
The evaluation of the effectiveness of Evidence based practice strategies in conjunction with the newer designed ETT 
like the KCHVLPMC tube to reduce the incidence of VAP in the ICU in an adult patient population. A reduction in 
VAP incidence and improved better patient care outcome are the effective goals to be met.
Problem Identification:
Increased incidence of VAP in spite of vent bundle protocols and 100% quality 
indicator (QI) compliance and other evidence based practice (EBP) strategies.
Inputs —► Constraints — Activities -> Outputs
r 1r r
^  - Small 20 bed ICU for data ^ - Noncompliance to any - Intermittent literature reviews from - Training \
collection VAP preventive numerous search engines for current - Data collection D/C on
- Hospital acquired Infection strategies EBP interventions to prevent VAP VAP incidence
(HAI) rates - Budget to replace ETT - Training of new product and - D/C on HAI
- HAI VAP rates throughout the rationale for change - D/C on mortality and
- Age of patient (pt) department that - Reinforcement of compliancy to morbidity associated
- Diagnosis of pt prior to performs intubation current in place prevention strategies with VAP
intubation - Existing culture to not - Defending the rationale for selecting - D/C on ventilator days
- Past history of pt change old system the KCHVLPMC over another ETT - D/C of length of stay
- Sputum and blood cultures - Time tubes (LOS)
prior to intubation - Small sample size due - Monitor practice of VAP prevention - D/C on cost
- Staff compliancy to infection to small hospital size strategies among healthcare providers - D/C on HAI rates
control standards and 150 bed acute care - Document standard of practice - D/C on VAP rates
ventilator bundle protocols facility (SOP) benchmarks using a SOP - Data on nurse/patient
- Mortality and Morbidity rate - Data from one facility Quality Improvement (QI) data ratios
hospital wide J V J collection form y - D/C on Vent Care QI
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Appendix C 
Measurement tool/instrument 
Context-Specific Database Draft
Month # of Patients Kimberly VAP # of VAP
on Ventilators Clark or Compliancy Ventilator Incidences
Mallinckodt QI Days
Ventilator QI
D ate:__________
Auditor’s Initials:
Room #
Medical Record #
7a 7p 7a 7p 7a 7p
Assigned RN Initials
1. Ventilator Order Set on Chart? Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
2. Ventilator Order Set completed 
and signed by the physician?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
3. Is it documented that the HOB is 
elevated 30-45 degrees at all times?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
4. Is a Sage 24 hr oral care kit in the 
room?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
5. Is mouth care documented every 2 
hrs on the CCU flow sheet?
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
6. Doe the caregiver wash hands or 
use alcohol based hand antiseptic 
before and after entering the patient’s 
room? (observe one caregiver)
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
7. Is there documentation regarding 
daily assessment of readiness to 
extubate (“sedation vacation”)?
* See respiratory flow sheet on the 
clipboard at the patient’s bedside.
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Comments
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Appendix D 
Timeframe
Timeframe
The time frame for the retrospective data collection was from February 27, until May 31, 2013. 
The data was collected on time and tabulated with results known as of July 4, 2013.
Appendix E
Budget and Resources Congruent with Objectives and Funding Source Identified
There are no budgetary concerns
- No additional education requirements
- No additional equipment to purchase
- No cost was incurred in the data collection
The KCHVLP ETT is currently implemented into practice (no resource supply issue)
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Appendix F
CITI Collaborative Institutional Training Initiative (CITI)
The RCR for Social & Behavioral Curriculum Completion Report 
Printed on 9/17/2012
Learner: Joyce Page (username: jpge)
Institution: Regis University
Contact Information Regis University
3333Regis BLVD 
Denver, Colorado 80221
The RCR for Social & Behavioral: This course is for investigators, staff and students with an interest or 
focus in Social and Behavioral research. This course contains text, embedded case studies AND quizzes.
Stage 1. RCR Passed on 09/17/12 (Ref # 8717519)
Required Modules
Date
Completed
Introduction to the Responsible Conduct of Research 09/17/12 no quiz
Research Misconduct 2-1495 09/17/12 5/5
(100%)
Case Study - Truth or Consequences 2-1217 09/17/12 2/3 (67%)
Case Study - In the Field, No One Will Know 2-1218 09/17/12 3/3
(100%)
Case Study Plagiarism 2-1472 09/17/12 2/2
(100%)
Human Subjects 13566 09/17/12 5/5
(100%)
For this Completion Report to be valid, the learner listed above must be affiliated with a CITI 
participating institution. Falsified information and unauthorized use of the CITI course site is 
unethical, and may be considered scientific misconduct by your institution.
Paul Braunschweiger Ph.D.
Professor, University of Miami 
Director Office of Research Education 
CITI Course Coordinator
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Appendix H
